Site Map
- Home
- Welcome to World Pharma Today
- Target Audience
- Knowledge Bank
- News
- Serious safety concerns around unlicensed ocular bevacizumab use versus Lucentis
- AstraZeneca to acquire Ardea Biosciences for $1 billion
- Key protein responsible for controlling nerve cell protection
- Rosetta wins European patent covering core element of microRNA technology
- Women don't receive the same treatment as men for heart disease the world-over
- Advances in personalized medicine for lung cancer
- Abbott reports positive levodopa-carbidopa intestinal gel study data
- VistaGen signs licensing deal for stem cell culture technology
- UCLA-engineered stem cells seek out and kill HIV in living organisms
- Takeda to Acquire URL Pharma
- Alzheimer's precursor protein controls its own fate
- Amgen to acquire privately held KAI Pharmaceuticals
- Indian government to address pharma industry issues
- Purdue Pharma announces availability of insomnia drug
- VitalMax unveils advanced vitamin formula to maintain glucose levels
- PolyTherics joins Spirogen to develop antibody-drug conjugates
- Scientists map new mechanism in brain's barrier tissue
- IMI funds platform to discover new medicines
- Schwartz Center Receives $500,000 Grant from the Amgen Foundation
- GSK announces submissions for two influenza vaccines
- Galapagos gets €3.5 mn milestones in osteoarthritis alliance with Servier
- Essentialis seeks patent for its investigational compound DCCR
- US FDA extends Eliquis action date by three months
- Dainippon Sumitomo Pharma signs pact to acquire US biotech company Boston Biomedical
- Inclinix partners with JSW for European enrolment support
- KCCI seeks leniency for pharma industry
- New suppliers to ease 2 cancer drug shortages
- Bristol-Myers Squibb Foundation Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia
- Bayer signs agreement to buy animal health business from KMG Chemicals
- US FDA accepts Santarus' Uceris NDA for induction of remission of active ulcerative colitis
- Merck Serono licenses Threshold cancer drug
- New cost-cutting Medicaid rule could save US billions
- Shire partners Sangamo to develop hemophilia treatments
- NanoViricides files FluCide pre-IND to FDA
- Orexo announces termination of OX-CLI and OX-ESI programs
- Precision receives US patent related to engineered meganucleases
- Vanda reports positive data of tasimelteon in Non-24-Hour Disorder
- Prosensa secures financing to develop RNA-modulating therapeutics
- Selventa receives new patent for discovery of biomarker profiles
- Upsher-Smith launches new prenatal vitamin
- Merck will pay a maximum of $37 million to settle all claims against its painkiller Vioxx in Canada.
- BTG receives US Voraxaze approval
- AstraZeneca and Bristol-Myers Squibb diabetes drug rejected by FDA
- Antidepressants cause three times more falls in people with dementia
- Totally drug-resistant TB found in Mumbai
- FDA calls for strictest warning on drug linked to brain infection
- AstraZeneca to enter into European evidence collaboration
- GSK responds to Argentinian court ruling over controversial vaccine trials
- LX4211 combination therapy found to treat type 2 diabetes
- Apricus, Abbott strike deal to commercialize Vitaros in Canada
- Novartis AG recalls 4 over-the-counter drugs
- US FDA grants orphan drug status to CanBas' CBP501 for malignant mesothelioma
- Acella Pharma acquires Prenate family of trademarks and associated IP
- Lilly Recognized as One of the Best Places to Work for LGBT Equality
- Eating disorders harm women's fertility
- EMA recognizes Takeda’s pioglitazone-containing medicines remain a valid treatment option for appropriate type 2 diabetes patients
- BYETTA Approved for Use with Insulin Glargine in the U.S.
- Vertex Submits Application for Priority Review and Approval of KALYDECO
- Oxford BioMedica Announces US IND Approval for Novel Ocular Product
- Norgine and Jubilant Announce Discovery Collaboration in Gastrointestinal Therapeutic Area
- Teva Completes Acquisition of Cephalon
- Agilent Technologies and Oxford Gene Technology Expand Microarray and Sequencing Partnership
- Ranbaxy Honored With Nabia Award For Excellence in New Jersey Business Expansion
- AstraZeneca sticks to R&D partnership track in China
- Sanofi Pasteur Donates Vaccine Strain Used for Polio Eradication to WHO
- CMC Biologics, Inspiration team up to manufacture hemophilia B drug
- Nuevolution signs agreement with Boehringer
- Moberg licenses OTC Nalox drug to Meda
- Cellerant gets additional funding from BARDA
- Ono Pharma to develop KAI Pharma hyperparathyroid drug
- Merck, BGI team up to develop biomarkers, genomic technologies
- Frontage, Spaulding strengthen business in China
- PharmAthene completes final commercial scale-up activities for SparVax
- Pfizer introduces new line of dietary supplements
- Malvern, Purdue collaborate to advance nanotechnology
- Harmonix introduces non-prescription sleep aid
- CellCura partners IDT Biologika for protein free media
- USP opens new testing facility in India
- BioVigilant submits rapid biologic detection systems DMFs with FDA
- Mannatech adds vitamin D to omega-3 supplement
- Isconova, Genocea widen licensing deal
- Alto Pharma to introduce DermSafe hand sanitizer
- SG Austria gets milestone payment
- Roche licenses vemurafenib to Chugai
- Mylan Pharma rolls out generic benign prostatic hyperplasia drug
- Anacor develops first candidate under Lilly pact
- Majority UK oncologists prefer Doctors.net.uk
- Adec, Zuellig Pharma in Pharma KPO joint venture
- Eteplirsen Shows Efficacy for Duchenne Muscular Dystrophy
- International Space Station Provides Pharmaceutical Insight
- Roche to Provide Early Infant Diagnosis HIV/AIDS Tests
- GlaxoSmithKline Flu Jab Linked to Sleep Disorder
- Europe Issues Warnings over Actos Cancer Risk
- American Regent Recalls Batch of Calcium Gluconate Injections
- Valeant to acquire Ortho Dermatologics
- Abbott Confirms Long-Term Commitment to HIV Care
- Novartis begins shipment of Fluvirin® seasonal influenza vaccine to US customers
- XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
- Roche provides update from FDA hearing on Avastin for metastatic breast cancer
- Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
- Pfizer to Explore Strategic Alternatives for its Animal Health and Nutrition Businesses
- Bristol-Myers Squibb and Innate Pharma Announce Breakthrough Global License Agreement
- Amgen and UCB Team Up with NASA on Final Space Shuttle Mission
- Medical Research Council Finds Antibody Capable of Fighting Flu
- GlaxoSmithKline and Valeant announce US FDA approval of Potiga
- Paladin And Elan Sign Agreement For New Pain Product
- Merck Statement Regarding FDA Approval of Changes to Trade Packaging Design
- Forest Laboratories, Inc. Announces Availability of Daliresp(TM) in Pharmacies
- Novagali Pharma and Ardeo sign an exclusive distribution agreement for Nova23041
- Synthes and Lilly Sign Development and Collaboration Agreement
- Kuecept present at Procept Spray Drying seminar in Barcelona
- Biogen Idec Receives Approval in the European Union for AVONEX(R) PEN
- Dr. Reddy’s announces three generic product launches in the US Market
- Bristol-Myers Squibb and Roche Enter into a Clinical Collaboration Agreement
- Cytokinetics to Present Clinical Data Relating to CK-2017357
- AstraZeneca signs agreement in Japan with Daiichi Sankyo
- Lend Lease sells King of Prussia mall
- CHMP Issues Positive Opinion for Merck's VICTRELIS
- Takeda to Acquire Nycomed
- RAUMEDIC and Sartorius Stedim Biotech Sign Partnership Agreement
- Clinical phase III studies of Lu AA21004 presented for the first time at the 2011 Annual Meeting
- Mylan Launches Generic Version of Percodan Tablets
- Sun Pharma announces USFDA approval for DOCEFREZTM for Injection
- Almac Introduces selectAZyme
- Seattle Genetics Announces Approval For FDA Accepts Brentuximab Vedotin BLAs
- Teva to Acquire Cephalon in $6.8 Billion Transaction
- Ranbaxy Launches Generic Olanzapine Tablets in Spain
- SGS Korea Lab becomes a Certified Body Technical Lab for Medical Devices
- Aurobindo Pharma receives final approval for Divalproex Sodium Delayed-Release Tablets
- Thermo Fisher Scientific Introduces New Cell Assay for Predictive Liver Toxicity Testing
- Novartis completes merger with Alcon
- NextPharma Announces the Addition of a New Encapsulation/Over-encapsulation Machine
- Thermo Fisher Scientific Completes Sales of Athena Diagnostics and Lancaster Laboratories
- Nycomed announces REACT study to evaluate impact of Daxas
- APP Pharmaceuticals issues nationwide voluntary recall of Irinotecan Hydrochloride Injection
- Lilly Announces New Vice President of Oncology Research
- AstraZeneca initiates phase III clinical programme evaluating NKTR-118
- Takeda’s Donation to Aid Earthquake Relief Efforts in Japan
- Amgen Donates $1 Million to Help Japanese Disaster Victims
- Bristol-Myers Squibb Foundation Announces Funding of Nearly $1 Million to China & India
- Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.
- Pharma Idol Winner Announced
- Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated
- BioSante Pharmaceuticals, Inc. To Present LibiGel® Safety Study Update At BIO CEO & Investor Conference
- First African country introduces GSK’s pneumococcal vaccine through innovative financing mechanism
- BIOTRONIK introduces new unique Reliaty Pacing System Analyzer
- Tobotec Signs Multiple Agreements With Generic Manufacturers To Provide New HIV Treatment
- Innovation drives Novartis to double-digit growth for 2010
- Aurobindo Pharma receives USFDA approval for Levofloxacin Tablets
- Covidien Announces Launch of Puritan Bennett(TM) 520 Portable Ventilator
- Mylan Receives Approval for Generic Version of Precose Tablets
- Boehringer Ingelheim to Purchase Amgen's Fremont Facility
- European Commission Clears Acquisition of Gensyme Corporation by sanofi-aventis
- Shionogi Inc announced availabilty of Kapvay
- Cell Biosciences Launches New Platform for Multiplex Western Blot Detection
- FDA extend review timeline for vandetanib new drug application
- Daxas (Roflumilast) included as a new treatment option in latest international COPD guidelines
- Merck to Hold Fourth-Quarter 2010 Sales and Earnings Conference Call on Feb. 3
- Teva Completes Acquisition of Theramex
- Novartis drug Tasigna received approval from the European Commission
- Arena and Eisai Complete End-of-Review Meeting with FDA
- Lundbeck enters into drug discovery collaboration with Zenobia and Vernalis
- Merck Serono and San Raffaele Institute to Collaborate on Research
- Addex Awarded EuropaBio’s Most Innovative SME Award
- Fluxion Biosciences Announces Product Launch of BioFlux 1000Z
- GSK signs agreement to acquire Nanjing MeiRui Pharmaceuticals
- Elan Drug Technologies Announces Completion of Enrolment in Phase 3
- Aurobindo Pharma receives FDA tentative approval for Duloxetine Hydrochloride Delayed Release Capsules
- Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting
- Merck to Acquire SmartCells, Inc
- Cold Chain Smart Solutions Conference
- Ranbaxy Launches Donepezil 5MG and 10MG Tablets
- Quintiles and London Genetics Alliance T0 Enchance Drug Discovery and Development
- Vertex Completes New Drug Application for Telaprevir for Hepatitis C
- Sun Pharma announces FDA tentative approval for generic Cymbalta
- Lilly and Acrux Receive FDA Approval for Axiron Topical Solution CIII
- VYTORIN the cholesterol-lowering medicine from Merck
- Antares Pharma Announces Next Generation of Auto-Injector Design
- Pfizer Announces Positive Phase 3 Trial Results for Axitinib
- Britannia innovates to provide Lifestyle Management Solutions for Diabetes
- Eisai Inc. Received U.S Food and Drug Administration for Eisai's Halaven Injection
- MorphoSys Launches New Antibody Technology
- Biomoda Selects Quintiles To Refine Lung Cancer Tests
- Boehringer Ingelheim entered into a collabration agreement with VTU Technology
- Columbia Asia performs its first stem cell transplant
- IntegenX Launches the Apollo 324 System for Automated DNA
- Merck To Present Innovative Products for Displays at the FPD International in Makuhari (Japan)
- Eli Lilly and Company received FDA approval for Cymbalta
- Eli Lilly to Open a Diabetes-Focused Research Center in China
- GlaxoSmithKline receives approval in Japan from the Ministry of Health
- Dako and Quintiles form alliance to speed development of personalized medicine
- Pfizer's Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan
- PRADAX gains approval in Canada for stroke prevention in atrial fibrillation
- Significant Milestone for Tengion Clinical Program Currently Enrolling Bladder Cancer Patients
- AstraZeneca initiates phase IIB study for AZD9773 (CytoFab) as a treatment for severe sepsis
- Cipla launches the world’s first generic Pirfenidone in India
- Sandoz announces launch of piperacillin and tazobactam for injection, a generic version of Zosyn
- Sanofi-aventis Establishes Research Collaboration with Harvard University
- Bharat Biotech Announces Launched Indias First Cell-culture H1N1 Swine Flu Vaccine
- FDA approved Dr. Reddy’s ANDA for Lansoprazole delayed-release capsules
- First HIV diagnostic assay Results Available in Less Than 50 Minutes
- Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
- Bristol-Myers Squibb Completes Acquisition of ZymoGenetics, Inc.
- BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX for Treatment of Peyronie’s Disease
- AstraZeneca and PoZEN received approval for VIMOVO in Europe
- Bexion Pharmaceuticals Continues to Gain Support from National Cancer Institute (NCI)
- Abbott Named One of the "Top Employers" in the Biotech and Pharmaceutical Industry by Science Magazine
- Lupin Announces Final FDA Approval of Generic Hyzaar® and Cozaar
- Mylan Launches Generic Version of Wellbutrin XL(R) Tablets
- Emisphere Reports Positive Clinical Results for Its Oral Drug Delivery Technology
- Movianto opens second warehouse in Orléans
- Ironwood and Forest Announce Positive Linaclotide Results from Phase 3
- Bristol-Myers Squibb Begins Tender Offer to Acquire ZymoGenetics, Inc.
- Dr Reddy’s launches darbepoetin alfa in India - World’s first generic darbepoetin alfa and the only one in India
- Glenmark announces the Discovery of a novel chemical entity 'GRC 17536', a potential first-in-class molecule globally
- Press Releases
- Biogen Idec to Present at the Deutsche Bank 37th Annual Healthcare Conference
- Anacor Pharmaceuticals to Present at the Deutsche Bank Annual Health Care Conference
- ClinStar to Present at Outsourcing in Clinical Trials Europe
- Novasep strengthens its management team with the appointment of Jean-Claude Romain as corporate quality director and Alain Lamproye as director of Novasep Bioproduction sites in Belgium
- Adocia reports positive phase II clinical results for the treatment of diabetic foot ulcer
- Novasep’s outstanding results in scale-up and biomanufacturing of Apo-A1 acknowledged by Cerenis at BioProcess International Conference
- Pharma Rural Marketing India 2012 - India’s most comprehensive conference on pharmaceutical marketing in the rural and semi-urban sector!
- According to PricewaterhouseCoopers, the Indian pharmaceutical market is expected to grow from US$11 billion to US$74 billion by 2020
- Immutep and Lonza sign agreement for cell line selection, cell banking and process development of ImmuFact(R) IMP321
- Novasep opens new 2,000 m2 expanded Shanghai facilities to meet increasing East Asia demand
- N3D Unveils the Next Generation of 3D Cell Culturing System
- Rhenovia launches drug discovery programs in rare, orphan and neglected neurodegenerative diseases
- AstraZeneca files lawsuit against the FDA for decision regarding quetiapine product labelling and exclusivity
- Boehringer Ingelheim expands capabilities in biopharmaceutical process science
- Cytheris announces results of phase II study indicating that recombinant Interleukin-7 (CYT107) expands CD4 T-cells in gut mucosa of chronically HIV infected immunological non-responder patients
- CiToxLAB increases inhalation test capabilities in North America and Europe
- Almac expands in US with addition of Commercial Packaging facility in Almac Group
- ELC Group expands India presence with new operation at heart of world’s largest pharmaceutical hub
- Pharmaceutical regulatory affairs specialist ELC Group opens new office in Mumbai
- BioCity Scotland joins forces with Harrison Goddard Foote
- BHMS Investments Acquires Osmotics
- European Commission approves Esmya® for the pre-operative treatment of uterine fibroids
- FDA Grants Orphan Drug Status for CF102 for the Treatment of Hepatocellular Carcinoma to Can-Fite BioPharma
- ELC Group launches new software subsidiary Pharma eReport to provide complete EVMPD compliance solution
- Provepharm announces impressive trading and financial results for 2011
- DNA Electronics CEO Professor Chris Toumazou To Address Scripps “Future of Genomic Medicine” Conference
- Ferrer announces best-in-class results in phase I for Lorediplon in insomnia
- Pharmaceutical regulatory affairs specialist ELC Group establishes global HQ in Cambridge, UK
- RBCC Negotiates Funding Terms With n3D
- Keller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding the Lo/Ovral®-28 and Norgestrel Birth Control Pill Recall
- Histogenics Corporation to Present at Canaccord Genuity Musculoskeletal Conference
- Alize Pharma licenses its ASPAREC(R) therapy for treatment of Acute Lymphoblastic Leukemia (ALL) to EUSA Pharma
- PerkinElmer Elects Peter Barrett to Board of Directors
- Unilens Vision Inc. Declares Quarterly Cash Dividend of $0.045 Per Share
- Hi-Tech Pharmacal Receives Final Approval for Lorazepam Oral Concentrate
- PharMerica Comments on FTC Decision to Block Omnicare’s Hostile Tender Offer
- Spectrum Pharmaceuticals Strengthens Commercial Operations
- Former FDA Senior Official Michael Chappell Joins Greenleaf Health LLC
- Rhenovia Pharma opens first US office
- NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray Product
- Polyplus-transfection launches the next generation PEI transfection reagent for bioproduction
- Incisive Surgical Announces Breakthrough Peer Review Clinical Study
- Klemens Schuette Appointed Managing Director at Ecron Acunova Germany (EAG)
- RBCC Enters New World of Opportunity
- BioReference Laboratories, Inc. Announces Contract with Corizon, Inc. to Provide Correctional Healthcare Laboratory Services
- A New Resource That Offers Personalized Nutritional Guidance to Achieve Better Health
- Kelly Brush Foundation Awards $100K Support For Ski Racing Safety and Adaptive Sports
- Bristol-Myers Squibb to Acquire Inhibitex
- Expert plastic surgeon offers free removal of PIP implants
- Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period
- Synta Pharmaceuticals Prices Public Offering of Common Stock
- Oncodesign and Ipsen enter into a research collaboration for the development of new therapeutic agents against the LRRK2 Parkinson's disease target
- World Pharma Today: Goose Bags Strides Arcolab, Indoco Remedies and Macleods ‘Track & Trace’ Deals
- Fluxion Biosciences Launches the F1 Giga-Ohm Seal Plates for the IonFlux System
- Cytheris announces interim results from ECLIPSE II Hepatitis C multicenter study of IL-7 in chronically infected genotype one and four nonresponders to standard of care (SOC)
- FDA Approves ERBITUX for First-Line Recurrent Locoregional or Metastatic Head and Neck Cancer in Combination with Platinum-based Chemotherapy with 5-Fluorouracil
- Trophos initiates phase II proof of concept study for novel cardioprotective compound, TRO40303, in acute myocardial infarction
- Hybrigenics’ specific inhibitor of Ubiquitin-Specific Protease 7 (USP7) is cytotoxic for chronic lymphocytic leukaemia (CLL) cells in vitro
- Cytheris to present interim data from ECLIPSE II Hepatitis C multicenter study at AASLD annual meeting
- Trophos hosts round-table meetings at ECTRIMS to design POC trial to treat progression in multiple sclerosis
- CertiVox wins prestigious 2011 Bully Awardsis
- TxCell presents final positive results of the phase I/II clinical trial with antigen-specific Treg cells in Crohn’s disease
- Taconic and Oncodesign announce agreement to co-promote and co-develop solutions to advance oncology research
- Rib-X Pharmaceuticals' RX-04 Program Yields Compounds with In Vitro Potency Against Multi-drug Resistant P. aeruginosa
- Further European Regulatory Review Clarifies and Confirms Prior CHMP Position on Positive Benefit-Risk Balance for Pioglitazone-Containing Products
- Cook Medical’s Zilver® PTX® Drug-Eluting Stent Technology Receives Unanimous Recommendation from FDA Advisory Committee
- Hybrigenics and Servier enter into a licence and research collaboration agreement in oncology and other therapeutic fields
- Global Bio-Pharma Clinical Leaders Call for Industry Transformation at 21st Annual Partnerships in Clinical Trials
- Genetic Technologies Limited Appoints Dr. Mervyn Cass as Company Director
- IBA’s Family of Proton Beam Solutions Suits Diverse Budgets, Sites and Clinical Needs
- TerraMedica To Become Fortel Analytics Fortel Analytics
- Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals
- Health Discovery Corporation Announces Issuance of First Patent Covering Prostate Cancer Biomarkers
- The 2011 Universal Biotech Innovation Prize was awarded to the French company MTP Therapeutics during the event on the 27th of September 2011, in Paris.
- Expoquimia hosts PharmaProcess, a space dedicated exclusively to the pharmaceutical industry
- More part-time chemistry degrees needed says Melbourn Scientific CEO
- Mayo Clinic Enters Collaboration That Takes Aim at Lou Gehrig’s Disease
- Mentorship programmes needed to encourage national nursing workforce in the UAE
- BIO Comments on New Initiatives to Grow Nation’s Bioeconomy
- Anesthesia Business Consultants Discusses HIPAA Privacy Rule Update for Anesthesiologists
- Polyplus-transfection announces the appointment of ten additional biologists and chemists to support multiple pre-clinical studies
- EcoCerta Biotecnologia Licenses Genetic ID’s GMO Testing Technology Genetic ID
- Less Than Half of Cancer Patients Informed of Fertility Preservation Options
- Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen, Inc.
- Mayo Clinic Teams with Glowing Cats Against AIDS, Other Diseases
- Exelixis Announces Webcasts of Upcoming Investor Conference Presentations Exelixis Inc.
- Sucampo and Numab Sign Drug Discovery Collaboration Sucampo Pharmaceuticals Inc. and Numab AG
- Trophos completes patient enrolment in pivotal efficacy study of olesoxime in Spinal Muscular Atrophy
- Over 65% of Physicians Have Used Social Media to Support their Professional Practice
- BARDA Partners to Develop New Class of Antibiotic U.S. Department of Health and Human Services
- Hybrigenics gets approval and funding for a Phase II clinical trial of inecalcitol in psoriasis
- Synta to Present at the Rodman & Renshaw Annual Global Investment Conference Synta Pharmaceuticals Corp.
- Launch of Cytocell Aquarius® FISH probe for Leukemia Patient Prognosis Cytocell Ltd
- Telemedicine Technology Links Rural Arizona to Concussion Care at Mayo Clinic
- STERIS invests in the future of sterilization monitoring STERIS
- Mannatech Enhances Omega-3 Supplement with Vitamin D Mannatech Incorporated
- Trophos awarded key US patent covering use of novel cardioprotective compound, TRO40303
- Hybrigenics maintains stable EUR two million revenues in first half of 2011
- Spire Corporation Awarded Patent for Nano-PV Devices Spire Corporation
- Osprey Medical Hires VP of Clinical & Regulatory Affairs Osprey Medical Inc
- Researchers Decode Genome of Atlantic Cod Using 454 Sequencing Systems Roche
- Avila Therapeutics Moves to New, Larger Facility
- Agios Founder and Advisor Publish In Nature Genetics On Further Links Between Serine Metabolic Pathway and Cancer
- The Staggering Price of Missing Regular Dental Visits 352 MEDIA GROUP
- UMass Medical School Selected to Provide Newborn Screening Services in Maine
- Evergreen Neurologist Co-Authors Key Study on Multiple Sclerosis Treatment Cost FIRMANI AND ASSOCIATES
- Novasep’s pharmaceutical production excellence in Europe and the Bahamas recognized by two successful FDA inspections in 2011
- BioPet Vet Lab Unveils Global “Proof of Parentage” Dog DNA Program
- Tempur-Med® Dental Chair Pad and Head Cushion Back by Popular Demand
- LEO Pharma A/S and The Scripps Research Institute Enter Collaboration
- Karen A. Dawes Elected as Repligen Co-chairperson of the Board of Directors Repligen Corporation
- Tension Launches New Brand Identity to Highlight Expanded Technology, Services and Global Presence
- Physician’s Preference Warns of FDA’s Assault on Dietary Supplements in US Physician’s Preference
- ELC GROUP aim to foster strategic and economic ties within India and China
- DaVita Rx Delivers Five Millionth Prescription
- Metabolons Vitamin D Deficiency Test Now Available for Patient Analysis Metabolon
- National Labor Union Apologizes for False and Defamatory Mass Mailing SUTTER HEALTH
- Diamyd Appoints Peter Zerhouni as President Diamyd Medical
- Merck Receives Approval to Market GARDASIL®, ZOLINZA® and CUBICIN® in Japan
- CiToxLAB appoints Paul C. Barrow as director of scientific projects and client consulting
- Alkermes Announces Positive Results from Clinical Study of ALKS 9070 For Treatment of Schizophrenia
- Provence Technologies and NexGenix announce successful lead compound development
- Adocia launches Phase IIa clinical study on type 1 diabetic patients with its fast-acting human insulin, HinsBet(R)
- PupPharma moves into the Biocitech science park
- Exclusive NHS Free podcast; Value Based Pricing: Do you get it?
- Integromics announces winners of proteomics grant competition
- Launch of new CiToxLAB group
- Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant in St. Petersburg, Russia
- Oroxcell granted good laboratory practice (GLP) certification by Afssaps
- Existing Research Ethics Protocols Fail in Biobanking Context
- Integromics launches OmicsHub Proteomics 2.0., a data management and analysis tool for mass spectrometry laboratories and core facilities
- InfoMedics Expands in Europe, Latin America and Asia-Pacific
- FDA accepts filing of New Drug Application for Nycomed’s ciclesonide HFA nasal aerosol
- Provepharm obtains European marketing authorization for its Methylthioninium Chloride Proveblue
- Sagent Pharmaceuticals Plans Launch of Piperacillin and Tazobactam, the Generic Form of Zosyn(R), for Injection
- Kodak Supports the Fight Against Counterfeit Pharmaceuticals
- Cytheris and CITN announce selection of recombinant interleukin-7 (CYT107) for initial studies at member institutions
- Roche and Merck Establish Strategic Agreements in Fight Against Chronic Hepatitis C
- FDA approves linagliptin tablets for the treatment of type 2 diabetes
- The European Commission Approves Pfizer’s Revatio for the Treatment of Pulmonary Arterial Hypertension in Children
- The American Society of Clinical Oncology and CollabRx Partner to Develop Online Apps for Planning Cancer Treatment
- Almac Introduces selectAZyme
- ISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase 2 Clinical Trial of Bepotastine Besilate Nasal Spray
- Wockhardt receives US FDA approval for generic version of Aricept tablets
- CIT/ABC acquires assets of LAB Research Inc.
- AMRI Announces Development and Commercial Supply Agreement with Parnell Manufacturing
- Lundbeck's partner Mochida receives approval of Lexapro in Japan
- Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851
- FDA Approves Roche’s HPV Test for Identifying Women at Highest Risk for Cervical Cancer
- BioSante Pharmaceuticals Announces Pancreatic and Prostate Cancer Vaccine License
- Trophos presents data at the American Academy of Neurology on SMA and MS
- CIT strengthens services in immunotoxicology
- PharmaDiagnostics’ SoPRano (TM) wins prestigious product award at SBS 2011
- Sun Pharma and Merck Establish Joint Venture to Develop and Commercialize Novel Formulations and Combinations of Medicines
- Integromics and Ingenuity expand their co-operation with the integration of a fourth Integromics product to Ingenuity’s IPA
- AstraZeneca demonstrates commitment to predictive science at international modelling conference
- Oncodesign offers world’s most comprehensive collection of patient-derived colorectal tumor models
- CIT launches LeadScreen (TM), a new range of fast, cost-effective services for drug candidate selection
- Ken Jones, COO Europe, Astellas joins GSK, Shire, Takeda and Bausch & Lomb on value based selling panel session
- Roche announces positive pivotal Phase II results for Hedgehog Pathway Inhibitor in advanced basal cell carcinoma
- Novartis completes acquisition of majority stake in Zhejiang Tianyuan
- Phase III Study of Investigational Compound Ipilimumab Achieves Primary Endpoint of Improvement in Overall Survival
- PharmaDiagnostics announces three new coupling methods for its SoPRano(TM) label-free platform
- Provepharm receives favorable EMA Review of its methylthioninium chloride Proveblue
- TxCell names François Meyer as CEO
- Oxford Medical Diagnostics and V&F join forces in the field of mass spectrometry
- Nycomed’s novel COPD therapy roflumilast receives FDA approval
- PharmaDiagnostics appoints director of assay development
- Patent plethora in 2010 breaks record for Biocitech technology park residents
- Apricus Biosciences Announced European Patient Coverage For Mycova For Nail Fungus
- Trophos successfully completes phase 1 study for novel cardioprotective compound, TRO40303
- Novartis gains positive CHMP opinion for Rasilamlo(TM), a single-pill combination of aliskiren and amlodipine to treat high blood pressure
- PharmaDiagnostics awarded European patent for label-free SoPRano ADME assays
- CIT and Stemina Biomarker Discovery announce partnership in Europe for stem cell based toxicology testing
- Personalized medicine: The partnership imperative
- Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines
- Gilead Sciences Refiles New Drug Application with the FDA for Single-Tablet Regimen of Truvada(R) and TMC278
- Elan and Boehringer Ingelheim Announce Development and Manufacturing Agreement for Elan’s Antibody-Based Therapeutics Pipeline
- Cancer Can Be Prevented-Latest cancer preventability data released to mark World Cancer Day
- Nycomed to acquire Colombian company Farmacol
- Lilly and the Juvenile Diabetes Research Foundation Partner to Fund Regenerative Medicine Research in Type 1 Diabetes
- HCPC Alliance at Pharma Packaging & Labelling Compliance Conference
- Eisai Receives Complete Response Letter from FDA for Rabeprazole Sodium Extended-Release Capsules
- 15 Merck & Co senior executives join the eyeforpharma Sales Force Effectiveness forum
- Protagen at the Personalized Medicine and Diagnostics Europe Congress 2011
- PIA Vietnam to return in March 2011 with broader focus
- Allan Mackintosh, PMAP Performance Coach, Grunenthal, on the evolving KAM approach
- Roche personalized investigational medicine shows survival benefit in advanced skin cancer
- ARIAD Announces Oral Ridaforolimus Achieved Primary Endpoint of Improved Progression-Free Survival in Patients
- Cook Medical’s Ongoing Drug-Eluting Peripheral Stent Trial Shows Consistent Outcomes
- Boehringer Ingelheim and Eli Lilly and Company Announce Strategic Alliance to Bring New Diabetes Treatments
- Sandoz announces phase II clinical trial for biosimilar version of leading monoclonal antibody rituximab
- Whats on the horizon for pharma sales- a look to the year ahead from UCB, Sanofi-Aventis & Actelion
- Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse Capsules
- Merck Expand Study Investigating Erbitux as 1st Line Treatment in Advanced Gastric Cancer Completes Recruitment
- KOMBIGLYZE XR Tablets, a New Treatment for Type 2 Diabetes Mellitus in Adults, Now Available in U.S. Pharmacies
- NovaBay Pharmaceuticals Reports Activity of Aganocide NVC-422 Against Deadly Superbug
- Lundbeck phase III studies confirm nalmefene as efficacious and safe in helping individuals to reduce their alcohol consumption
- Personalised Medicine and Diagnostics Europe 2011
- King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY
- Sanofi-aventis Acquires from Ascendis Pharma Worldwide Rights on Drug-Delivery
- Bristol-Myers Squibb Company and Pfizer Inc.announced that the ADVANCE-3 study results
- Novartis drug Tasigna approved in Japan for treatment of patients with newly diagnosed Ph+ chronic myeloid leukemia
- Lilly Announces Completion of Avid Acquisition and FDA Priority Review for florbetapir
- Merck KGaA and sanofi-aventis Sign Agreement to Jointly Investigate Novel Combinations Against Cancer
- Malaria Vaccine Initiative, Merck and NYU Langone Medical Center Collaborate to Research Potential Malaria Vaccine
- New subgroup analysis of the LUX-Lung 1 trial suggests benefit from afatinib in lung cancer patients
- The R and D Leaders Band Together at Discovery Summit 2011 to Uncover Innovative Solutions
- Phase 2 Interim Data Show High Objective Response Rate for Patients Treated with Elotuzumab plus
- FDA Advisory Committee Recommends Approval to Expand Use of LAP-BAND® Adjustable Gastric Banding System for Obese Adults
- Next-Generation Cell Sorter from Beckman Coulter Enables Multi-Color Flow Cytometry Studies
- Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
- Life Technologies Wins Top Ten Innovations of the Year Award
- Selcia and Gilead Sciences Extend Liver Disease Drug Discovery Collaboration
- Micell Technologies Enrolls First Patient in DESSOLVE I First-In-Human Study of MiStent DES
- BG Medicine Announces FDA Clearance of its Galectin-3 Test for Use in Patients with Chronic HF
- NanoString Launches First Simple and Precise Approach to Detect Hundreds of Genetic Copy Variants in a Single Multiplexed Reaction
- Merrion Pharmaceuticals Plc announces commencement of feasibility and option agreement with Rebel Pharmaceuticals
- Abbott Announces Positive Results from Phase 2 Study of Low Dose Atrasentan for Treatment of Diabetic Kidney Disease
- Reata and Abbott Announce Positive Phase 2b Study Results for Bardoxolone Methyl
- Novartis unveils long-term strategy to grow in a dynamically changing healthcare environment
- Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships
- Pfizer Inc, Study Shows Adding INSPRA to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure
- Forest Laboratories Enters Collaboration on Bystolic(R) and Savella(R)
- Endo Pharmaceuticals Announces That FDA Eliminates Need for Advisory Committee Meeting to Discuss New Formulation of Long-Acting Oxymorphone
- Abbott Wins Two Scrip Awards Recognizing Excellence in Pharmaceutical and Biotech Industries
- Nycomed to acquire of majority stake in Guangdong Techpool Bio-Pharma
- PTC Therapeutics Initiates Phase 2 Clinical Trial of Ataluren in Patients with Methylmalonic Acidemia
- Celator Pharmaceuticals completes enrollment in a second phase 2 trail of CPX-351in acute myeloid leukemia
- Eurand Presents Data on ZENPEP(R) Without Proton Pump Inhibitors or H2 Receptor Antagonists in Patients With CF and Pancreatic Insufficiency
- Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL
- FDA approves Herceptin for HER2-positive metastatic stomach cancer
- Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON(TM)
- NeurogesX to Pursue Expanded U.S Label for Qutenza(R) 8% Patch in HIV-Associated Neuropathy
- Endress+Hauser Announces Collaboration with SAP as a Core Partner of the Future Factory Initiative of the SAP Research Center in Dresden
- Italvacuum to Attend India CHEM 2010
- AVEVA to Exhibit at Drug Delivery Partnerships 2011
- APR and Labtec enter into exclusive License Agreement with Ferrer International
- Genzyme’s Alemtuzumab Shows Sustained Reduction in Relapses and Disability in Five-Year Review of MS Patients from Phase 2 Trial
- Weight Watchers and Merck Collaborate to Help Physicians Fight Obesity Through Lifestyle Management Approach
- Pfizer to Acquire King Pharmaceuticals, Inc.
- ImmunoGen, Inc. Announces Positive Interim Results in Randomized Clinical Trial
- AJ Precision Components to Exhibit at Interplas 2011
- APR and Labtec enter into exclusive License Agreement with Ferrer International
- Baxter Receives Approval For PREFLUCEL Seasonal Influenza Vaccine In Austria
- Baxter Receives Approval For PREFLUCEL Seasonal Influenza Vaccine In Austria
- Johnson & Johnson Completes Acquisition of Micrus Endovascular
- BRILIQUE (ticagrelor) receives positive opinion from European CHMP for the treatment of Acute Coronary Syndromes
- FLUOstar Omega Named Drug Discovery Product of the Year 2010
- Emisphere Reports Positive Clinical Results for Its Oral Drug Delivery Technology in Appetite Suppression Study
- Out Now: Rotronic Humidity News 2010
- HIV-1 patients with an undetectable viral load can switch to VIRAMUNE® regardless of their CD4 count
- Ensure FDA and EMA Compliance with Continuous Monitoring Records, 24/7 Alarming and Automated Reporting
- Lundbeck wins Federal Trade Commission case in Federal District Court
- SolidWorks 3D with Rutek
- The HygroPalm23 Cased Set Guarantees Efficient Measurement of Water Activity
- Epistem Announce Agency Agreement With Veritas Japan
- Rutek Introduces New 3,000mm Roller
- Custom Sensors & Technology
- Custom Sensors & Technology
- Rutek Gains New Stainless-Steel Welding Certification
- Italvacuum Introduces a New Range of Tray Vacuum Dryers Designed for Laboratory Scale
- Best Practice in Pumps for WFI Systems
- Metastorm Selected for the 2010 AlwaysOn East Top 100 Private Companies List
- LEWA Encourages Experts to Discuss Energy Efficiency at Green Technologies Day
- ChargePoint Technology ltd
- Allegheny Bradford Corporation to Exhibit at Interphex 2010
- Allegheny Bradford Corporation to Exhibit Throughout the Year
- The New HygroFlex8 - The All-in-One Industrial Transmitter from Rotronic
- A&B Process Systems to Exhibit its Sanitary Process Vessels, Skids and Piping at Interphex New York
- Optimising Quality and Production in the Pharmaceutical and Dietary Supplement Industries
- BMG Labtech to Showcase the PHERAstar FS Reader and Other Microplate Readers at Analytica 2010
- GERTEIS to Exhibit its Roller Compactors and Dry Granulation Systems at INTERPHEX 2010
- LEWA to Exhibit its Pumps and Pump Systems at INTERPHEX Puerto Rico 2010
- New Compact and Intelligent Conveyors from FlexLink
- B. Braun Releases New White Paper: Products, Project Management and Services for the Healthcare Industry
- Allegheny Bradford Corporation to Attend Interphex Canada 2009
- BIOQUELL Opens New UK Manufacturing Site
- Russell Finex Introduces its Revolutionary New Compact Airlock Sieve™
- Russell Finex Introduces its Revolutionary New Compact Airlock Sieve™
- Italvacuum Thanks Visitors at ACHEMA 2009, Frankfurt, Germany
- Metastorm Releases New Whitepaper
- New Facility Forms Core for Sustainable Future at Flexitallic
- New Dewpoint Transmitter from Vaisala for Very Dry Gases
- The Most Flexible Just Got More Flexible
- New Conveyor Chains for Handling of Lightweight Goods
- Intelligent Single-Piece Flow Solution by FlexLink
- Miniature Humidity Probe from Vaisala
- Use of a Modified Starch for Softgel Coating, Suitable for Food, Nutraceutical and Pharmaceutical Products
- Industry Reports
- Pfizer reports first-quarter 2012 results
- Revenue of first quarter 2012
- Pfizer reports fourth-quarter and full-year 2011 results
- NxStage® to Report Fourth Quarter and Full Year 2011 Financial Results
- Cubist Pharmaceuticals Reports 2011 Fourth Quarter and Full Year Financial Results
- Stable consolidated revenues, costs and losses for Hybrigenics
- Hikma Pharma Q1 revenue rises
- Furiex Pharmaceuticals Enters into Loan Agreement for up to $15 Million Furiex Pharmaceuticals Inc.
- China Shenghuo Q2 sales climb 58%
- Vivus reports Qnexa phase 3 study results
- Novartis delivers strong financial results and four major approvals
- Echo Therapeutics Announces First Quarter 2011 Financial Results
- ELC Group announces doubled revenues
- GlaxoSmithKline Pharmaceuticals Net Sales up 11.4%
- GlaxoSmithKline Pharmaceuticals profit grows by 16%
- Impax Laboratories Reports First Quarter 2011 Financial Results
- IMS Institute Reports U.S. Spending on Medicines Grew 2.3 Percent in 2010, to $307.4 Billion
- Novo Nordisk increased operating profit by 27% in 2010
- Pfizer Reports Fourth-Quarter and Full-Year 2010 Results
- Innovation drives Novartis to double-digit growth for 2010
- Genzyme Financial Recovery Continues in Fourth Quarter
- IMS Health Forecasts Global Pharmaceutical Market Growth of 5-7 Percent in 2011, Reaching $880 Billion
- BioMimetic Therapeutics Reports 2010 Third Quarter Earnings Results
- GlaxoSmithKline announced third quarter results-Net Sales growth of 14% compared to the previous quarter
- Bayer lifts sales-Grow by 16.1 percent to EUR 8,581 million
- ICON reports revenues of $225 million up 2% on prior year
- Pfizer Entering into a partnership with Laboratorio Teuto Brasileiro S.A to develop and commercialize generic medicines
- Genzyme Reports Financial Results for the Third-quarter revenue was $1.0 billion,
- Teva to Report Third Quarter 2010 Financial Results on November 2, 2010
- Cephalon Reports Record Sales - Quaterly sales increased 32% percent
- Ranbaxy Achieves USD 1 Billion Revenue
- King Pharmaceuticals, Inc announced total revenue for the second quarter ended June 30, 2010
- Amylin Pharmaceuticals Reports Second Quarter Results total revenue of $164.4 for the quarter ended June 30, 2010
- Research Insight
- Warfarin and aspirin are similar in heart failure treatment
- Researchers Refine Nanoparticles For More Accurate Delivery Of Cancer Drugs
- Mylan introduces new antiepileptic drug
- Vidacare study reveals IO infusion equivalent to IV in Therapeutic Hypothermia
- Ovarian cancer study proves drug delays disease progression
- New data confirm the benefits of early and first line treatment with Betaferon® in Multiple Sclerosis (MS)
- EU study shows once-daily lisdexamfetamine dimesylate (LDX) effective for symptom control in children and adolescents with ADHD
- NIH researchers show how anti-HIV drug acts to block herpes virus
- New Study Shows Cialis® Significantly Improved Study Endpoints in Men
- Hybrigenics' inecalcitol inhibits the growth of human hormone-dependent prostate cancer cells in vitro and in vivo
- New Study Released Showed Patients With Deadly Form of Lung Cancer Lived Longer Without Disease Worsening
- King’s College London Prostate cancer treatment study shows percentage of men who had a radical prostatectomy survived for 15 years
- Abbott and Enanta Present Positive 12-Week Results and 3-Day Resistance Data from Phase 2 Study of ABT-450/r
- Cytheris announces results of phase IIa study indicating that recombinant interleukin-7 (CYT107)
- Progenics Reports Positive Preliminary Data from Ongoing Phase 1 Clinical Study of PSMA ADC
- New potential drug targets discovered for preventing prostate cancer cell growth
- Manhattan Research’s ePharma Consumer study provides in-depth info about pharma product websites
- Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study
- Pro-Pharmaceuticals and Mount Sinai annouced New Liver Fibrosis Research Collaboration
- New data show potential for Novartis Meningitis B vaccine candidate to cover majority of diverse meningococcal serogroup B strains
- University of Rochester Spearheads FDA Initiative to Speed Development of New Therapies
- Phase II Study with Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis Patients
- 21-Year Long-term Follow-up Study Demonstrates Significant Survival Advantage with Betaferon Treatment
- Sanofi-aventis announced the results from the two year phase III TEMSO study of teriflunomide
- Novartis Phase III study of Afinitor® plus Sandostatin® LAR® in patients with advanced neuroendocrine tumors showing potential benefit
- Afatinib (BIBW 2992*) triples progression free survival in phase III study in lung cancer patients
- The GRACE study has significant implications for inclusion of women in clinical trials
- Novartis study shows Onbrez® Breezhaler® is superior to salmeterol in reducing breathlessness for patients with COPD
- Genetic substudy shows fewer major cardiovascular events with ticagrelor (brilinta) regardless of relevant genetic variability in ACS patients
- New Study Reinforces Safety Profile of GARDASIL®, the Cervical Cancer Vaccine
- Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced final results from a retrospective study
- What is the difference between Archiving and Trashing an Article?
- Techno Trends
- Medicago to develop new VLP vaccine candidate for rabies
- Benefits of statin therapy may extend beyond lowering lipids
- Hepatitis C virus hijacks liver microRNA
- Oral therapy with Teriflunomide reduces relapses in multiple sclerosis
- CRANE ChemPharma Flow Solutions Launches New Interactive BioPharm Applications Module
- Novel Hepatitis C Vaccine First Effective Way
- Oracle Introduces Oracle Health Sciences InForm Global Trial Management 5.5
- U.S. Southeast 'Stroke Belt' Also Shows Higher Rates of Cognitive Decline
- Omega-3 Fatty Acids Help Heart Patients With Stents
- Novozymes Biopharma collaborates with the University of Oslo to develop enhanced albumin fusion technology
- Topman Announces Exclusive Sunglasses for Rock You Shades Day
- Veeva Launches First iPad CRM/CLM Cloud Application
- Cipla introduces new pain free screening technology for early detection of breast cancer in India
- New Technology Platform For Testing Drugs
- Treating Cancer with Light
- Merck KGaA to Introduce RebiDose, the Rebif Single Use Pre-filled Pen for Treatment of Multiple Sclerosis
- UCSB scientists discover inner workings of potent cancer drug
- InnerCap Technologies offers Combinaton Capsule Technology
- BD Biosciences Introduces CD4 Testing Product in collaboration with ReaMetrix That Does Not Require Refrigeration
- 3M™ Nasal Metered Dose Inhaler -Effective Way To Deliver Inhaled Corticosteroids For Allergic Rhinitis And Other Nasal Treatments.
- Articles
- Why streamlining pharma supply chain is essential
- Can pharma truly embrace social media?
- Joining forces to beat cancer in Asia
- Social media and the pharma industry
- Pharma goes mobile: Making the most of the app opportunity
- Can personalised medicine save the pharma sector?
- Utilising a CTMS to Create a Development Edge
- Scientist gets his mind around Alzheimer’s
- Rodent models meeting need for reduced drug attrition rates
- Exploring Opportunities in Chemical Biology
- Maximising Drug Discovery Research
- State of the industry and the future of the sales force
- Bottlenecks in vaccine development: Eliminate from the beginning
- Bringing in the Green
- What do mapping and imaging techniques add to traditional spectroscopic analysis for pharmaceutical applications?
- Biogen Idec to Present at the Deutsche Bank 37th Annual Healthcare Conference
- Serious safety concerns around unlicensed ocular bevacizumab use versus Lucentis
- Anacor Pharmaceuticals to Present at the Deutsche Bank Annual Health Care Conference
- Pfizer reports first-quarter 2012 results
- ClinStar to Present at Outsourcing in Clinical Trials Europe
- Revenue of first quarter 2012
- AstraZeneca to acquire Ardea Biosciences for $1 billion
- Novasep strengthens its management team with the appointment of Jean-Claude Romain as corporate quality director and Alain Lamproye as director of Novasep Bioproduction sites in Belgium
- Key protein responsible for controlling nerve cell protection
- Adocia reports positive phase II clinical results for the treatment of diabetic foot ulcer
- Rosetta wins European patent covering core element of microRNA technology
- Women don't receive the same treatment as men for heart disease the world-over
- Advances in personalized medicine for lung cancer
- Abbott reports positive levodopa-carbidopa intestinal gel study data
- VistaGen signs licensing deal for stem cell culture technology
- Novasep’s outstanding results in scale-up and biomanufacturing of Apo-A1 acknowledged by Cerenis at BioProcess International Conference
- Pharma Rural Marketing India 2012 - India’s most comprehensive conference on pharmaceutical marketing in the rural and semi-urban sector!
- According to PricewaterhouseCoopers, the Indian pharmaceutical market is expected to grow from US$11 billion to US$74 billion by 2020
- UCLA-engineered stem cells seek out and kill HIV in living organisms
- Takeda to Acquire URL Pharma
- Immutep and Lonza sign agreement for cell line selection, cell banking and process development of ImmuFact(R) IMP321
- Alzheimer's precursor protein controls its own fate
- Amgen to acquire privately held KAI Pharmaceuticals
- Indian government to address pharma industry issues
- Purdue Pharma announces availability of insomnia drug
- VitalMax unveils advanced vitamin formula to maintain glucose levels
- PolyTherics joins Spirogen to develop antibody-drug conjugates
- Novasep opens new 2,000 m2 expanded Shanghai facilities to meet increasing East Asia demand
- N3D Unveils the Next Generation of 3D Cell Culturing System
- Rhenovia launches drug discovery programs in rare, orphan and neglected neurodegenerative diseases
- AstraZeneca files lawsuit against the FDA for decision regarding quetiapine product labelling and exclusivity
- Scientists map new mechanism in brain's barrier tissue
- Boehringer Ingelheim expands capabilities in biopharmaceutical process science
- Cytheris announces results of phase II study indicating that recombinant Interleukin-7 (CYT107) expands CD4 T-cells in gut mucosa of chronically HIV infected immunological non-responder patients
- CiToxLAB increases inhalation test capabilities in North America and Europe
- IMI funds platform to discover new medicines
- Schwartz Center Receives $500,000 Grant from the Amgen Foundation
- Almac expands in US with addition of Commercial Packaging facility in Almac Group
- ELC Group expands India presence with new operation at heart of world’s largest pharmaceutical hub
- GSK announces submissions for two influenza vaccines
- Pharmaceutical regulatory affairs specialist ELC Group opens new office in Mumbai
- Galapagos gets €3.5 mn milestones in osteoarthritis alliance with Servier
- BioCity Scotland joins forces with Harrison Goddard Foote
- Essentialis seeks patent for its investigational compound DCCR
- US FDA extends Eliquis action date by three months
- BHMS Investments Acquires Osmotics
- Dainippon Sumitomo Pharma signs pact to acquire US biotech company Boston Biomedical
- European Commission approves Esmya® for the pre-operative treatment of uterine fibroids
- Inclinix partners with JSW for European enrolment support
- KCCI seeks leniency for pharma industry
- FDA Grants Orphan Drug Status for CF102 for the Treatment of Hepatocellular Carcinoma to Can-Fite BioPharma
- New suppliers to ease 2 cancer drug shortages
- ELC Group launches new software subsidiary Pharma eReport to provide complete EVMPD compliance solution
- Bristol-Myers Squibb Foundation Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia
- Bayer signs agreement to buy animal health business from KMG Chemicals
- US FDA accepts Santarus' Uceris NDA for induction of remission of active ulcerative colitis
- Provepharm announces impressive trading and financial results for 2011
- DNA Electronics CEO Professor Chris Toumazou To Address Scripps “Future of Genomic Medicine” Conference
- Ferrer announces best-in-class results in phase I for Lorediplon in insomnia
- Pharmaceutical regulatory affairs specialist ELC Group establishes global HQ in Cambridge, UK
- Merck Serono licenses Threshold cancer drug
- RBCC Negotiates Funding Terms With n3D
- Warfarin and aspirin are similar in heart failure treatment
- Keller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding the Lo/Ovral®-28 and Norgestrel Birth Control Pill Recall
- Histogenics Corporation to Present at Canaccord Genuity Musculoskeletal Conference
- New cost-cutting Medicaid rule could save US billions
- Alize Pharma licenses its ASPAREC(R) therapy for treatment of Acute Lymphoblastic Leukemia (ALL) to EUSA Pharma
- PerkinElmer Elects Peter Barrett to Board of Directors
- Shire partners Sangamo to develop hemophilia treatments
- Pfizer reports fourth-quarter and full-year 2011 results
- NanoViricides files FluCide pre-IND to FDA
- Unilens Vision Inc. Declares Quarterly Cash Dividend of $0.045 Per Share
- Orexo announces termination of OX-CLI and OX-ESI programs
- Hi-Tech Pharmacal Receives Final Approval for Lorazepam Oral Concentrate
- Precision receives US patent related to engineered meganucleases
- PharMerica Comments on FTC Decision to Block Omnicare’s Hostile Tender Offer
- Vanda reports positive data of tasimelteon in Non-24-Hour Disorder
- Spectrum Pharmaceuticals Strengthens Commercial Operations
- Prosensa secures financing to develop RNA-modulating therapeutics
- Former FDA Senior Official Michael Chappell Joins Greenleaf Health LLC
- Rhenovia Pharma opens first US office
- Selventa receives new patent for discovery of biomarker profiles
- Upsher-Smith launches new prenatal vitamin
- Researchers Refine Nanoparticles For More Accurate Delivery Of Cancer Drugs
- Merck will pay a maximum of $37 million to settle all claims against its painkiller Vioxx in Canada.
- NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray Product
- BTG receives US Voraxaze approval
- NxStage® to Report Fourth Quarter and Full Year 2011 Financial Results
- Cubist Pharmaceuticals Reports 2011 Fourth Quarter and Full Year Financial Results
- Mylan introduces new antiepileptic drug
- Medicago to develop new VLP vaccine candidate for rabies
- AstraZeneca and Bristol-Myers Squibb diabetes drug rejected by FDA
- Antidepressants cause three times more falls in people with dementia
- Polyplus-transfection launches the next generation PEI transfection reagent for bioproduction
- Totally drug-resistant TB found in Mumbai
- Vidacare study reveals IO infusion equivalent to IV in Therapeutic Hypothermia
- FDA calls for strictest warning on drug linked to brain infection
- Incisive Surgical Announces Breakthrough Peer Review Clinical Study
- AstraZeneca to enter into European evidence collaboration
- Klemens Schuette Appointed Managing Director at Ecron Acunova Germany (EAG)
- RBCC Enters New World of Opportunity
- GSK responds to Argentinian court ruling over controversial vaccine trials
- BioReference Laboratories, Inc. Announces Contract with Corizon, Inc. to Provide Correctional Healthcare Laboratory Services
- A New Resource That Offers Personalized Nutritional Guidance to Achieve Better Health
- LX4211 combination therapy found to treat type 2 diabetes
- Kelly Brush Foundation Awards $100K Support For Ski Racing Safety and Adaptive Sports
- Apricus, Abbott strike deal to commercialize Vitaros in Canada
- Novartis AG recalls 4 over-the-counter drugs
- Bristol-Myers Squibb to Acquire Inhibitex
- Expert plastic surgeon offers free removal of PIP implants
- Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period
- US FDA grants orphan drug status to CanBas' CBP501 for malignant mesothelioma
- Acella Pharma acquires Prenate family of trademarks and associated IP
- Synta Pharmaceuticals Prices Public Offering of Common Stock
- Benefits of statin therapy may extend beyond lowering lipids
- Oncodesign and Ipsen enter into a research collaboration for the development of new therapeutic agents against the LRRK2 Parkinson's disease target
- Hepatitis C virus hijacks liver microRNA
- Ovarian cancer study proves drug delays disease progression
- Lilly Recognized as One of the Best Places to Work for LGBT Equality
- World Pharma Today: Goose Bags Strides Arcolab, Indoco Remedies and Macleods ‘Track & Trace’ Deals
- Fluxion Biosciences Launches the F1 Giga-Ohm Seal Plates for the IonFlux System
- Eating disorders harm women's fertility
- Cytheris announces interim results from ECLIPSE II Hepatitis C multicenter study of IL-7 in chronically infected genotype one and four nonresponders to standard of care (SOC)
- FDA Approves ERBITUX for First-Line Recurrent Locoregional or Metastatic Head and Neck Cancer in Combination with Platinum-based Chemotherapy with 5-Fluorouracil
- Trophos initiates phase II proof of concept study for novel cardioprotective compound, TRO40303, in acute myocardial infarction
- Hybrigenics’ specific inhibitor of Ubiquitin-Specific Protease 7 (USP7) is cytotoxic for chronic lymphocytic leukaemia (CLL) cells in vitro
- Cytheris to present interim data from ECLIPSE II Hepatitis C multicenter study at AASLD annual meeting
- Trophos hosts round-table meetings at ECTRIMS to design POC trial to treat progression in multiple sclerosis
- CertiVox wins prestigious 2011 Bully Awardsis
- TxCell presents final positive results of the phase I/II clinical trial with antigen-specific Treg cells in Crohn’s disease
- Taconic and Oncodesign announce agreement to co-promote and co-develop solutions to advance oncology research
- New data confirm the benefits of early and first line treatment with Betaferon® in Multiple Sclerosis (MS)
- EMA recognizes Takeda’s pioglitazone-containing medicines remain a valid treatment option for appropriate type 2 diabetes patients
- EU study shows once-daily lisdexamfetamine dimesylate (LDX) effective for symptom control in children and adolescents with ADHD
- Oral therapy with Teriflunomide reduces relapses in multiple sclerosis
- Rib-X Pharmaceuticals' RX-04 Program Yields Compounds with In Vitro Potency Against Multi-drug Resistant P. aeruginosa
- Further European Regulatory Review Clarifies and Confirms Prior CHMP Position on Positive Benefit-Risk Balance for Pioglitazone-Containing Products
- BYETTA Approved for Use with Insulin Glargine in the U.S.
- NIH researchers show how anti-HIV drug acts to block herpes virus
- Vertex Submits Application for Priority Review and Approval of KALYDECO
- Stable consolidated revenues, costs and losses for Hybrigenics
- Oxford BioMedica Announces US IND Approval for Novel Ocular Product
- Norgine and Jubilant Announce Discovery Collaboration in Gastrointestinal Therapeutic Area
- Teva Completes Acquisition of Cephalon
- Agilent Technologies and Oxford Gene Technology Expand Microarray and Sequencing Partnership
- Cook Medical’s Zilver® PTX® Drug-Eluting Stent Technology Receives Unanimous Recommendation from FDA Advisory Committee
- New Study Shows Cialis® Significantly Improved Study Endpoints in Men
- Ranbaxy Honored With Nabia Award For Excellence in New Jersey Business Expansion
- Hybrigenics and Servier enter into a licence and research collaboration agreement in oncology and other therapeutic fields
- Global Bio-Pharma Clinical Leaders Call for Industry Transformation at 21st Annual Partnerships in Clinical Trials
- CRANE ChemPharma Flow Solutions Launches New Interactive BioPharm Applications Module
- Genetic Technologies Limited Appoints Dr. Mervyn Cass as Company Director
- IBA’s Family of Proton Beam Solutions Suits Diverse Budgets, Sites and Clinical Needs
- TerraMedica To Become Fortel Analytics Fortel Analytics
- Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals
- Health Discovery Corporation Announces Issuance of First Patent Covering Prostate Cancer Biomarkers
- The 2011 Universal Biotech Innovation Prize was awarded to the French company MTP Therapeutics during the event on the 27th of September 2011, in Paris.
- Expoquimia hosts PharmaProcess, a space dedicated exclusively to the pharmaceutical industry
- AstraZeneca sticks to R&D partnership track in China
- Sanofi Pasteur Donates Vaccine Strain Used for Polio Eradication to WHO
- CMC Biologics, Inspiration team up to manufacture hemophilia B drug
- More part-time chemistry degrees needed says Melbourn Scientific CEO
- Nuevolution signs agreement with Boehringer
- Mayo Clinic Enters Collaboration That Takes Aim at Lou Gehrig’s Disease
- Moberg licenses OTC Nalox drug to Meda
- Mentorship programmes needed to encourage national nursing workforce in the UAE
- BIO Comments on New Initiatives to Grow Nation’s Bioeconomy
- Anesthesia Business Consultants Discusses HIPAA Privacy Rule Update for Anesthesiologists
- Cellerant gets additional funding from BARDA
- Polyplus-transfection announces the appointment of ten additional biologists and chemists to support multiple pre-clinical studies
- EcoCerta Biotecnologia Licenses Genetic ID’s GMO Testing Technology Genetic ID
- Ono Pharma to develop KAI Pharma hyperparathyroid drug
- Less Than Half of Cancer Patients Informed of Fertility Preservation Options
- Merck, BGI team up to develop biomarkers, genomic technologies
- Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen, Inc.
- Frontage, Spaulding strengthen business in China
- Mayo Clinic Teams with Glowing Cats Against AIDS, Other Diseases
- PharmAthene completes final commercial scale-up activities for SparVax
- Exelixis Announces Webcasts of Upcoming Investor Conference Presentations Exelixis Inc.
- Sucampo and Numab Sign Drug Discovery Collaboration Sucampo Pharmaceuticals Inc. and Numab AG
- Pfizer introduces new line of dietary supplements
- Trophos completes patient enrolment in pivotal efficacy study of olesoxime in Spinal Muscular Atrophy
- Over 65% of Physicians Have Used Social Media to Support their Professional Practice
- Malvern, Purdue collaborate to advance nanotechnology
- BARDA Partners to Develop New Class of Antibiotic U.S. Department of Health and Human Services
- Harmonix introduces non-prescription sleep aid
- Hybrigenics gets approval and funding for a Phase II clinical trial of inecalcitol in psoriasis
- Synta to Present at the Rodman & Renshaw Annual Global Investment Conference Synta Pharmaceuticals Corp.
- CellCura partners IDT Biologika for protein free media
- Launch of Cytocell Aquarius® FISH probe for Leukemia Patient Prognosis Cytocell Ltd
- USP opens new testing facility in India
- Telemedicine Technology Links Rural Arizona to Concussion Care at Mayo Clinic
- STERIS invests in the future of sterilization monitoring STERIS
- BioVigilant submits rapid biologic detection systems DMFs with FDA
- Mannatech Enhances Omega-3 Supplement with Vitamin D Mannatech Incorporated
- Mannatech adds vitamin D to omega-3 supplement
- Hikma Pharma Q1 revenue rises
- Trophos awarded key US patent covering use of novel cardioprotective compound, TRO40303
- Hybrigenics maintains stable EUR two million revenues in first half of 2011
- Isconova, Genocea widen licensing deal
- Furiex Pharmaceuticals Enters into Loan Agreement for up to $15 Million Furiex Pharmaceuticals Inc.
- Alto Pharma to introduce DermSafe hand sanitizer
- Spire Corporation Awarded Patent for Nano-PV Devices Spire Corporation
- SG Austria gets milestone payment
- Osprey Medical Hires VP of Clinical & Regulatory Affairs Osprey Medical Inc
- China Shenghuo Q2 sales climb 58%
- Roche licenses vemurafenib to Chugai
- Mylan Pharma rolls out generic benign prostatic hyperplasia drug
- Researchers Decode Genome of Atlantic Cod Using 454 Sequencing Systems Roche
- Anacor develops first candidate under Lilly pact
- Avila Therapeutics Moves to New, Larger Facility
- Majority UK oncologists prefer Doctors.net.uk
- Adec, Zuellig Pharma in Pharma KPO joint venture
- Vivus reports Qnexa phase 3 study results
- Agios Founder and Advisor Publish In Nature Genetics On Further Links Between Serine Metabolic Pathway and Cancer
- The Staggering Price of Missing Regular Dental Visits 352 MEDIA GROUP
- UMass Medical School Selected to Provide Newborn Screening Services in Maine
- Evergreen Neurologist Co-Authors Key Study on Multiple Sclerosis Treatment Cost FIRMANI AND ASSOCIATES
- Eteplirsen Shows Efficacy for Duchenne Muscular Dystrophy
- Novel Hepatitis C Vaccine First Effective Way
- International Space Station Provides Pharmaceutical Insight
- Novasep’s pharmaceutical production excellence in Europe and the Bahamas recognized by two successful FDA inspections in 2011
- Roche to Provide Early Infant Diagnosis HIV/AIDS Tests
- GlaxoSmithKline Flu Jab Linked to Sleep Disorder
- Europe Issues Warnings over Actos Cancer Risk
- American Regent Recalls Batch of Calcium Gluconate Injections
- Novartis delivers strong financial results and four major approvals
- Valeant to acquire Ortho Dermatologics
- BioPet Vet Lab Unveils Global “Proof of Parentage” Dog DNA Program
- Abbott Confirms Long-Term Commitment to HIV Care
- Tempur-Med® Dental Chair Pad and Head Cushion Back by Popular Demand
- Novartis begins shipment of Fluvirin® seasonal influenza vaccine to US customers
- LEO Pharma A/S and The Scripps Research Institute Enter Collaboration
- Karen A. Dawes Elected as Repligen Co-chairperson of the Board of Directors Repligen Corporation
- XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
- Tension Launches New Brand Identity to Highlight Expanded Technology, Services and Global Presence
- Roche provides update from FDA hearing on Avastin for metastatic breast cancer
- Physician’s Preference Warns of FDA’s Assault on Dietary Supplements in US Physician’s Preference
- Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
- ELC GROUP aim to foster strategic and economic ties within India and China
- Hybrigenics' inecalcitol inhibits the growth of human hormone-dependent prostate cancer cells in vitro and in vivo
- Pfizer to Explore Strategic Alternatives for its Animal Health and Nutrition Businesses
- Bristol-Myers Squibb and Innate Pharma Announce Breakthrough Global License Agreement
- DaVita Rx Delivers Five Millionth Prescription
- Metabolons Vitamin D Deficiency Test Now Available for Patient Analysis Metabolon
- National Labor Union Apologizes for False and Defamatory Mass Mailing SUTTER HEALTH
- Amgen and UCB Team Up with NASA on Final Space Shuttle Mission
- Diamyd Appoints Peter Zerhouni as President Diamyd Medical
- Merck Receives Approval to Market GARDASIL®, ZOLINZA® and CUBICIN® in Japan
- CiToxLAB appoints Paul C. Barrow as director of scientific projects and client consulting
- Alkermes Announces Positive Results from Clinical Study of ALKS 9070 For Treatment of Schizophrenia
- Medical Research Council Finds Antibody Capable of Fighting Flu
- Provence Technologies and NexGenix announce successful lead compound development
- Adocia launches Phase IIa clinical study on type 1 diabetic patients with its fast-acting human insulin, HinsBet(R)
- PupPharma moves into the Biocitech science park
- Exclusive NHS Free podcast; Value Based Pricing: Do you get it?
- Integromics announces winners of proteomics grant competition
- Launch of new CiToxLAB group
- Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant in St. Petersburg, Russia
- Oroxcell granted good laboratory practice (GLP) certification by Afssaps
- GlaxoSmithKline and Valeant announce US FDA approval of Potiga
- Paladin And Elan Sign Agreement For New Pain Product
- Merck Statement Regarding FDA Approval of Changes to Trade Packaging Design
- Existing Research Ethics Protocols Fail in Biobanking Context
- Forest Laboratories, Inc. Announces Availability of Daliresp(TM) in Pharmacies
- Novagali Pharma and Ardeo sign an exclusive distribution agreement for Nova23041
- Synthes and Lilly Sign Development and Collaboration Agreement
- Integromics launches OmicsHub Proteomics 2.0., a data management and analysis tool for mass spectrometry laboratories and core facilities
- Oracle Introduces Oracle Health Sciences InForm Global Trial Management 5.5
- Kuecept present at Procept Spray Drying seminar in Barcelona
- Biogen Idec Receives Approval in the European Union for AVONEX(R) PEN
- InfoMedics Expands in Europe, Latin America and Asia-Pacific
- FDA accepts filing of New Drug Application for Nycomed’s ciclesonide HFA nasal aerosol
- Dr. Reddy’s announces three generic product launches in the US Market
- New Study Released Showed Patients With Deadly Form of Lung Cancer Lived Longer Without Disease Worsening
- Bristol-Myers Squibb and Roche Enter into a Clinical Collaboration Agreement
- Echo Therapeutics Announces First Quarter 2011 Financial Results
- Cytokinetics to Present Clinical Data Relating to CK-2017357
- ELC Group announces doubled revenues
- Provepharm obtains European marketing authorization for its Methylthioninium Chloride Proveblue
- AstraZeneca signs agreement in Japan with Daiichi Sankyo
- Lend Lease sells King of Prussia mall
- Sagent Pharmaceuticals Plans Launch of Piperacillin and Tazobactam, the Generic Form of Zosyn(R), for Injection
- U.S. Southeast 'Stroke Belt' Also Shows Higher Rates of Cognitive Decline
- CHMP Issues Positive Opinion for Merck's VICTRELIS
- Kodak Supports the Fight Against Counterfeit Pharmaceuticals
- Takeda to Acquire Nycomed
- RAUMEDIC and Sartorius Stedim Biotech Sign Partnership Agreement
- Why streamlining pharma supply chain is essential
- Cytheris and CITN announce selection of recombinant interleukin-7 (CYT107) for initial studies at member institutions
- Roche and Merck Establish Strategic Agreements in Fight Against Chronic Hepatitis C
- Omega-3 Fatty Acids Help Heart Patients With Stents
- Clinical phase III studies of Lu AA21004 presented for the first time at the 2011 Annual Meeting
- Can pharma truly embrace social media?
- FDA approves linagliptin tablets for the treatment of type 2 diabetes
- GlaxoSmithKline Pharmaceuticals Net Sales up 11.4%
- GlaxoSmithKline Pharmaceuticals profit grows by 16%
- Mylan Launches Generic Version of Percodan Tablets
- The European Commission Approves Pfizer’s Revatio for the Treatment of Pulmonary Arterial Hypertension in Children
- Novozymes Biopharma collaborates with the University of Oslo to develop enhanced albumin fusion technology
- King’s College London Prostate cancer treatment study shows percentage of men who had a radical prostatectomy survived for 15 years
- The American Society of Clinical Oncology and CollabRx Partner to Develop Online Apps for Planning Cancer Treatment
- Sun Pharma announces USFDA approval for DOCEFREZTM for Injection
- Almac Introduces selectAZyme
- Almac Introduces selectAZyme
- Impax Laboratories Reports First Quarter 2011 Financial Results
- Seattle Genetics Announces Approval For FDA Accepts Brentuximab Vedotin BLAs
- Teva to Acquire Cephalon in $6.8 Billion Transaction
- Ranbaxy Launches Generic Olanzapine Tablets in Spain
- ISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase 2 Clinical Trial of Bepotastine Besilate Nasal Spray
- SGS Korea Lab becomes a Certified Body Technical Lab for Medical Devices
- Wockhardt receives US FDA approval for generic version of Aricept tablets
- Topman Announces Exclusive Sunglasses for Rock You Shades Day
- CIT/ABC acquires assets of LAB Research Inc.
- AMRI Announces Development and Commercial Supply Agreement with Parnell Manufacturing
- Aurobindo Pharma receives final approval for Divalproex Sodium Delayed-Release Tablets
- Veeva Launches First iPad CRM/CLM Cloud Application
- Thermo Fisher Scientific Introduces New Cell Assay for Predictive Liver Toxicity Testing
- Lundbeck's partner Mochida receives approval of Lexapro in Japan
- Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851
- FDA Approves Roche’s HPV Test for Identifying Women at Highest Risk for Cervical Cancer
- IMS Institute Reports U.S. Spending on Medicines Grew 2.3 Percent in 2010, to $307.4 Billion
- BioSante Pharmaceuticals Announces Pancreatic and Prostate Cancer Vaccine License
- Trophos presents data at the American Academy of Neurology on SMA and MS
- Joining forces to beat cancer in Asia
- CIT strengthens services in immunotoxicology
- PharmaDiagnostics’ SoPRano (TM) wins prestigious product award at SBS 2011
- Sun Pharma and Merck Establish Joint Venture to Develop and Commercialize Novel Formulations and Combinations of Medicines
- Novartis completes merger with Alcon
- NextPharma Announces the Addition of a New Encapsulation/Over-encapsulation Machine
- Integromics and Ingenuity expand their co-operation with the integration of a fourth Integromics product to Ingenuity’s IPA
- Social media and the pharma industry
- Cipla introduces new pain free screening technology for early detection of breast cancer in India
- AstraZeneca demonstrates commitment to predictive science at international modelling conference
- Thermo Fisher Scientific Completes Sales of Athena Diagnostics and Lancaster Laboratories
- Abbott and Enanta Present Positive 12-Week Results and 3-Day Resistance Data from Phase 2 Study of ABT-450/r
- Nycomed announces REACT study to evaluate impact of Daxas
- Oncodesign offers world’s most comprehensive collection of patient-derived colorectal tumor models
- CIT launches LeadScreen (TM), a new range of fast, cost-effective services for drug candidate selection
- APP Pharmaceuticals issues nationwide voluntary recall of Irinotecan Hydrochloride Injection
- Ken Jones, COO Europe, Astellas joins GSK, Shire, Takeda and Bausch & Lomb on value based selling panel session
- Cytheris announces results of phase IIa study indicating that recombinant interleukin-7 (CYT107)
- Pharma goes mobile: Making the most of the app opportunity
- Roche announces positive pivotal Phase II results for Hedgehog Pathway Inhibitor in advanced basal cell carcinoma
- Novartis completes acquisition of majority stake in Zhejiang Tianyuan
- Phase III Study of Investigational Compound Ipilimumab Achieves Primary Endpoint of Improvement in Overall Survival
- PharmaDiagnostics announces three new coupling methods for its SoPRano(TM) label-free platform
- Can personalised medicine save the pharma sector?
- Utilising a CTMS to Create a Development Edge
- Lilly Announces New Vice President of Oncology Research
- AstraZeneca initiates phase III clinical programme evaluating NKTR-118
- Takeda’s Donation to Aid Earthquake Relief Efforts in Japan
- Amgen Donates $1 Million to Help Japanese Disaster Victims
- Provepharm receives favorable EMA Review of its methylthioninium chloride Proveblue
- Bristol-Myers Squibb Foundation Announces Funding of Nearly $1 Million to China & India
- TxCell names François Meyer as CEO
- Oxford Medical Diagnostics and V&F join forces in the field of mass spectrometry
- Scientist gets his mind around Alzheimer’s
- Nycomed’s novel COPD therapy roflumilast receives FDA approval
- PharmaDiagnostics appoints director of assay development
- Patent plethora in 2010 breaks record for Biocitech technology park residents
- Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.
- Apricus Biosciences Announced European Patient Coverage For Mycova For Nail Fungus
- Trophos successfully completes phase 1 study for novel cardioprotective compound, TRO40303
- Novartis gains positive CHMP opinion for Rasilamlo(TM), a single-pill combination of aliskiren and amlodipine to treat high blood pressure
- PharmaDiagnostics awarded European patent for label-free SoPRano ADME assays
- Pharma Idol Winner Announced
- Progenics Reports Positive Preliminary Data from Ongoing Phase 1 Clinical Study of PSMA ADC
- CIT and Stemina Biomarker Discovery announce partnership in Europe for stem cell based toxicology testing
- New potential drug targets discovered for preventing prostate cancer cell growth
- Rodent models meeting need for reduced drug attrition rates
- Personalized medicine: The partnership imperative
- Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated
- Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines
- BioSante Pharmaceuticals, Inc. To Present LibiGel® Safety Study Update At BIO CEO & Investor Conference
- Gilead Sciences Refiles New Drug Application with the FDA for Single-Tablet Regimen of Truvada(R) and TMC278
- Elan and Boehringer Ingelheim Announce Development and Manufacturing Agreement for Elan’s Antibody-Based Therapeutics Pipeline
- First African country introduces GSK’s pneumococcal vaccine through innovative financing mechanism
- Cancer Can Be Prevented-Latest cancer preventability data released to mark World Cancer Day
- BIOTRONIK introduces new unique Reliaty Pacing System Analyzer
- Nycomed to acquire Colombian company Farmacol
- Lilly and the Juvenile Diabetes Research Foundation Partner to Fund Regenerative Medicine Research in Type 1 Diabetes
- HCPC Alliance at Pharma Packaging & Labelling Compliance Conference
- Eisai Receives Complete Response Letter from FDA for Rabeprazole Sodium Extended-Release Capsules
- Novo Nordisk increased operating profit by 27% in 2010
- 15 Merck & Co senior executives join the eyeforpharma Sales Force Effectiveness forum
- Pfizer Reports Fourth-Quarter and Full-Year 2010 Results
- Manhattan Research’s ePharma Consumer study provides in-depth info about pharma product websites
- Protagen at the Personalized Medicine and Diagnostics Europe Congress 2011
- Exploring Opportunities in Chemical Biology
- Maximising Drug Discovery Research
- Tobotec Signs Multiple Agreements With Generic Manufacturers To Provide New HIV Treatment
- New Technology Platform For Testing Drugs
- Innovation drives Novartis to double-digit growth for 2010
- Innovation drives Novartis to double-digit growth for 2010
- PIA Vietnam to return in March 2011 with broader focus
- Allan Mackintosh, PMAP Performance Coach, Grunenthal, on the evolving KAM approach
- Aurobindo Pharma receives USFDA approval for Levofloxacin Tablets
- State of the industry and the future of the sales force
- Covidien Announces Launch of Puritan Bennett(TM) 520 Portable Ventilator
- Roche personalized investigational medicine shows survival benefit in advanced skin cancer
- Mylan Receives Approval for Generic Version of Precose Tablets
- Boehringer Ingelheim to Purchase Amgen's Fremont Facility
- ARIAD Announces Oral Ridaforolimus Achieved Primary Endpoint of Improved Progression-Free Survival in Patients
- Cook Medical’s Ongoing Drug-Eluting Peripheral Stent Trial Shows Consistent Outcomes
- European Commission Clears Acquisition of Gensyme Corporation by sanofi-aventis
- Shionogi Inc announced availabilty of Kapvay
- Boehringer Ingelheim and Eli Lilly and Company Announce Strategic Alliance to Bring New Diabetes Treatments
- Genzyme Financial Recovery Continues in Fourth Quarter
- Sandoz announces phase II clinical trial for biosimilar version of leading monoclonal antibody rituximab
- Whats on the horizon for pharma sales- a look to the year ahead from UCB, Sanofi-Aventis & Actelion
- Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse Capsules
- Merck Expand Study Investigating Erbitux as 1st Line Treatment in Advanced Gastric Cancer Completes Recruitment
- Cell Biosciences Launches New Platform for Multiplex Western Blot Detection
- KOMBIGLYZE XR Tablets, a New Treatment for Type 2 Diabetes Mellitus in Adults, Now Available in U.S. Pharmacies
- FDA extend review timeline for vandetanib new drug application
- Daxas (Roflumilast) included as a new treatment option in latest international COPD guidelines
- NovaBay Pharmaceuticals Reports Activity of Aganocide NVC-422 Against Deadly Superbug
- Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study
- Merck to Hold Fourth-Quarter 2010 Sales and Earnings Conference Call on Feb. 3
- Teva Completes Acquisition of Theramex
- Novartis drug Tasigna received approval from the European Commission
- Lundbeck phase III studies confirm nalmefene as efficacious and safe in helping individuals to reduce their alcohol consumption
- Personalised Medicine and Diagnostics Europe 2011
- King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY
- Sanofi-aventis Acquires from Ascendis Pharma Worldwide Rights on Drug-Delivery
- Bristol-Myers Squibb Company and Pfizer Inc.announced that the ADVANCE-3 study results
- Pro-Pharmaceuticals and Mount Sinai annouced New Liver Fibrosis Research Collaboration
- Arena and Eisai Complete End-of-Review Meeting with FDA
- Novartis drug Tasigna approved in Japan for treatment of patients with newly diagnosed Ph+ chronic myeloid leukemia
- Lundbeck enters into drug discovery collaboration with Zenobia and Vernalis
- Lilly Announces Completion of Avid Acquisition and FDA Priority Review for florbetapir
- Merck KGaA and sanofi-aventis Sign Agreement to Jointly Investigate Novel Combinations Against Cancer
- Malaria Vaccine Initiative, Merck and NYU Langone Medical Center Collaborate to Research Potential Malaria Vaccine
- Merck Serono and San Raffaele Institute to Collaborate on Research
- Addex Awarded EuropaBio’s Most Innovative SME Award
- New subgroup analysis of the LUX-Lung 1 trial suggests benefit from afatinib in lung cancer patients
- Fluxion Biosciences Announces Product Launch of BioFlux 1000Z
- The R and D Leaders Band Together at Discovery Summit 2011 to Uncover Innovative Solutions
- Phase 2 Interim Data Show High Objective Response Rate for Patients Treated with Elotuzumab plus
- GSK signs agreement to acquire Nanjing MeiRui Pharmaceuticals
- FDA Advisory Committee Recommends Approval to Expand Use of LAP-BAND® Adjustable Gastric Banding System for Obese Adults
- Elan Drug Technologies Announces Completion of Enrolment in Phase 3
- IMS Health Forecasts Global Pharmaceutical Market Growth of 5-7 Percent in 2011, Reaching $880 Billion
- Next-Generation Cell Sorter from Beckman Coulter Enables Multi-Color Flow Cytometry Studies
- Aurobindo Pharma receives FDA tentative approval for Duloxetine Hydrochloride Delayed Release Capsules
- Bottlenecks in vaccine development: Eliminate from the beginning
- Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting
- Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
- Life Technologies Wins Top Ten Innovations of the Year Award
- Merck to Acquire SmartCells, Inc
- Cold Chain Smart Solutions Conference
- Ranbaxy Launches Donepezil 5MG and 10MG Tablets
- Selcia and Gilead Sciences Extend Liver Disease Drug Discovery Collaboration
- Quintiles and London Genetics Alliance T0 Enchance Drug Discovery and Development
- Micell Technologies Enrolls First Patient in DESSOLVE I First-In-Human Study of MiStent DES
- BG Medicine Announces FDA Clearance of its Galectin-3 Test for Use in Patients with Chronic HF
- Vertex Completes New Drug Application for Telaprevir for Hepatitis C
- Sun Pharma announces FDA tentative approval for generic Cymbalta
- NanoString Launches First Simple and Precise Approach to Detect Hundreds of Genetic Copy Variants in a Single Multiplexed Reaction
- Lilly and Acrux Receive FDA Approval for Axiron Topical Solution CIII
- Merrion Pharmaceuticals Plc announces commencement of feasibility and option agreement with Rebel Pharmaceuticals
- Abbott Announces Positive Results from Phase 2 Study of Low Dose Atrasentan for Treatment of Diabetic Kidney Disease
- VYTORIN the cholesterol-lowering medicine from Merck
- Reata and Abbott Announce Positive Phase 2b Study Results for Bardoxolone Methyl
- Antares Pharma Announces Next Generation of Auto-Injector Design
- Pfizer Announces Positive Phase 3 Trial Results for Axitinib
- Novartis unveils long-term strategy to grow in a dynamically changing healthcare environment
- Britannia innovates to provide Lifestyle Management Solutions for Diabetes
- Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships
- Eisai Inc. Received U.S Food and Drug Administration for Eisai's Halaven Injection
- Pfizer Inc, Study Shows Adding INSPRA to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure
- MorphoSys Launches New Antibody Technology
- Biomoda Selects Quintiles To Refine Lung Cancer Tests
- Boehringer Ingelheim entered into a collabration agreement with VTU Technology
- Forest Laboratories Enters Collaboration on Bystolic(R) and Savella(R)
- Columbia Asia performs its first stem cell transplant
- Endo Pharmaceuticals Announces That FDA Eliminates Need for Advisory Committee Meeting to Discuss New Formulation of Long-Acting Oxymorphone
- IntegenX Launches the Apollo 324 System for Automated DNA
- Abbott Wins Two Scrip Awards Recognizing Excellence in Pharmaceutical and Biotech Industries
- Merck To Present Innovative Products for Displays at the FPD International in Makuhari (Japan)
- Eli Lilly and Company received FDA approval for Cymbalta
- New data show potential for Novartis Meningitis B vaccine candidate to cover majority of diverse meningococcal serogroup B strains
- BioMimetic Therapeutics Reports 2010 Third Quarter Earnings Results
- Eli Lilly to Open a Diabetes-Focused Research Center in China
- GlaxoSmithKline receives approval in Japan from the Ministry of Health
- Nycomed to acquire of majority stake in Guangdong Techpool Bio-Pharma
- University of Rochester Spearheads FDA Initiative to Speed Development of New Therapies
- Dako and Quintiles form alliance to speed development of personalized medicine
- GlaxoSmithKline announced third quarter results-Net Sales growth of 14% compared to the previous quarter
- Pfizer's Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan
- PRADAX gains approval in Canada for stroke prevention in atrial fibrillation
- Bayer lifts sales-Grow by 16.1 percent to EUR 8,581 million
- PTC Therapeutics Initiates Phase 2 Clinical Trial of Ataluren in Patients with Methylmalonic Acidemia
- Significant Milestone for Tengion Clinical Program Currently Enrolling Bladder Cancer Patients
- Celator Pharmaceuticals completes enrollment in a second phase 2 trail of CPX-351in acute myeloid leukemia
- AstraZeneca initiates phase IIB study for AZD9773 (CytoFab) as a treatment for severe sepsis
- Cipla launches the world’s first generic Pirfenidone in India
- Bringing in the Green
- Eurand Presents Data on ZENPEP(R) Without Proton Pump Inhibitors or H2 Receptor Antagonists in Patients With CF and Pancreatic Insufficiency
- ICON reports revenues of $225 million up 2% on prior year
- Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL
- Pfizer Entering into a partnership with Laboratorio Teuto Brasileiro S.A to develop and commercialize generic medicines
- Sandoz announces launch of piperacillin and tazobactam for injection, a generic version of Zosyn
- FDA approves Herceptin for HER2-positive metastatic stomach cancer
- Genzyme Reports Financial Results for the Third-quarter revenue was $1.0 billion,
- Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON(TM)
- Phase II Study with Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis Patients
- Sanofi-aventis Establishes Research Collaboration with Harvard University
- NeurogesX to Pursue Expanded U.S Label for Qutenza(R) 8% Patch in HIV-Associated Neuropathy
- Treating Cancer with Light
- Bharat Biotech Announces Launched Indias First Cell-culture H1N1 Swine Flu Vaccine
- Endress+Hauser Announces Collaboration with SAP as a Core Partner of the Future Factory Initiative of the SAP Research Center in Dresden
- Italvacuum to Attend India CHEM 2010
- AVEVA to Exhibit at Drug Delivery Partnerships 2011
- APR and Labtec enter into exclusive License Agreement with Ferrer International
- Genzyme’s Alemtuzumab Shows Sustained Reduction in Relapses and Disability in Five-Year Review of MS Patients from Phase 2 Trial
- FDA approved Dr. Reddy’s ANDA for Lansoprazole delayed-release capsules
- 21-Year Long-term Follow-up Study Demonstrates Significant Survival Advantage with Betaferon Treatment
- Sanofi-aventis announced the results from the two year phase III TEMSO study of teriflunomide
- Merck KGaA to Introduce RebiDose, the Rebif Single Use Pre-filled Pen for Treatment of Multiple Sclerosis
- First HIV diagnostic assay Results Available in Less Than 50 Minutes
- Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
- UCSB scientists discover inner workings of potent cancer drug
- Weight Watchers and Merck Collaborate to Help Physicians Fight Obesity Through Lifestyle Management Approach
- Bristol-Myers Squibb Completes Acquisition of ZymoGenetics, Inc.
- Pfizer to Acquire King Pharmaceuticals, Inc.
- BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX for Treatment of Peyronie’s Disease
- Teva to Report Third Quarter 2010 Financial Results on November 2, 2010
- Novartis Phase III study of Afinitor® plus Sandostatin® LAR® in patients with advanced neuroendocrine tumors showing potential benefit
- Afatinib (BIBW 2992*) triples progression free survival in phase III study in lung cancer patients
- AstraZeneca and PoZEN received approval for VIMOVO in Europe
- InnerCap Technologies offers Combinaton Capsule Technology
- ImmunoGen, Inc. Announces Positive Interim Results in Randomized Clinical Trial
- Cephalon Reports Record Sales - Quaterly sales increased 32% percent
- Bexion Pharmaceuticals Continues to Gain Support from National Cancer Institute (NCI)
- Abbott Named One of the "Top Employers" in the Biotech and Pharmaceutical Industry by Science Magazine
- Lupin Announces Final FDA Approval of Generic Hyzaar® and Cozaar
- AJ Precision Components to Exhibit at Interplas 2011
- APR and Labtec enter into exclusive License Agreement with Ferrer International
- Mylan Launches Generic Version of Wellbutrin XL(R) Tablets
- Baxter Receives Approval For PREFLUCEL Seasonal Influenza Vaccine In Austria
- Baxter Receives Approval For PREFLUCEL Seasonal Influenza Vaccine In Austria
- Johnson & Johnson Completes Acquisition of Micrus Endovascular
- BRILIQUE (ticagrelor) receives positive opinion from European CHMP for the treatment of Acute Coronary Syndromes
- FLUOstar Omega Named Drug Discovery Product of the Year 2010
- The GRACE study has significant implications for inclusion of women in clinical trials
- Novartis study shows Onbrez® Breezhaler® is superior to salmeterol in reducing breathlessness for patients with COPD
- Emisphere Reports Positive Clinical Results for Its Oral Drug Delivery Technology
- Emisphere Reports Positive Clinical Results for Its Oral Drug Delivery Technology in Appetite Suppression Study
- Out Now: Rotronic Humidity News 2010
- HIV-1 patients with an undetectable viral load can switch to VIRAMUNE® regardless of their CD4 count
- Movianto opens second warehouse in Orléans
- Ensure FDA and EMA Compliance with Continuous Monitoring Records, 24/7 Alarming and Automated Reporting
- Ironwood and Forest Announce Positive Linaclotide Results from Phase 3
- Bristol-Myers Squibb Begins Tender Offer to Acquire ZymoGenetics, Inc.
- Dr Reddy’s launches darbepoetin alfa in India - World’s first generic darbepoetin alfa and the only one in India
- Lundbeck wins Federal Trade Commission case in Federal District Court
- SolidWorks 3D with Rutek
- The HygroPalm23 Cased Set Guarantees Efficient Measurement of Water Activity
- Epistem Announce Agency Agreement With Veritas Japan
- Glenmark announces the Discovery of a novel chemical entity 'GRC 17536', a potential first-in-class molecule globally
- Genetic substudy shows fewer major cardiovascular events with ticagrelor (brilinta) regardless of relevant genetic variability in ACS patients
- Rutek Introduces New 3,000mm Roller
- Custom Sensors & Technology
- Custom Sensors & Technology
- New Study Reinforces Safety Profile of GARDASIL®, the Cervical Cancer Vaccine
- Rutek Gains New Stainless-Steel Welding Certification
- Ranbaxy Achieves USD 1 Billion Revenue
- King Pharmaceuticals, Inc announced total revenue for the second quarter ended June 30, 2010
- Italvacuum Introduces a New Range of Tray Vacuum Dryers Designed for Laboratory Scale
- Amylin Pharmaceuticals Reports Second Quarter Results total revenue of $164.4 for the quarter ended June 30, 2010
- BD Biosciences Introduces CD4 Testing Product in collaboration with ReaMetrix That Does Not Require Refrigeration
- Best Practice in Pumps for WFI Systems
- Metastorm Selected for the 2010 AlwaysOn East Top 100 Private Companies List
- Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced final results from a retrospective study
- LEWA Encourages Experts to Discuss Energy Efficiency at Green Technologies Day
- 3M™ Nasal Metered Dose Inhaler -Effective Way To Deliver Inhaled Corticosteroids For Allergic Rhinitis And Other Nasal Treatments.
- ChargePoint Technology ltd
- Allegheny Bradford Corporation to Exhibit at Interphex 2010
- Allegheny Bradford Corporation to Exhibit Throughout the Year
- The New HygroFlex8 - The All-in-One Industrial Transmitter from Rotronic
- A&B Process Systems to Exhibit its Sanitary Process Vessels, Skids and Piping at Interphex New York
- What do mapping and imaging techniques add to traditional spectroscopic analysis for pharmaceutical applications?
- Optimising Quality and Production in the Pharmaceutical and Dietary Supplement Industries
- BMG Labtech to Showcase the PHERAstar FS Reader and Other Microplate Readers at Analytica 2010
- GERTEIS to Exhibit its Roller Compactors and Dry Granulation Systems at INTERPHEX 2010
- LEWA to Exhibit its Pumps and Pump Systems at INTERPHEX Puerto Rico 2010
- New Compact and Intelligent Conveyors from FlexLink
- B. Braun Releases New White Paper: Products, Project Management and Services for the Healthcare Industry
- Allegheny Bradford Corporation to Attend Interphex Canada 2009
- BIOQUELL Opens New UK Manufacturing Site
- Russell Finex Introduces its Revolutionary New Compact Airlock Sieve™
- Russell Finex Introduces its Revolutionary New Compact Airlock Sieve™
- Italvacuum Thanks Visitors at ACHEMA 2009, Frankfurt, Germany
- Metastorm Releases New Whitepaper
- New Facility Forms Core for Sustainable Future at Flexitallic
- What is the difference between Archiving and Trashing an Article?
- New Dewpoint Transmitter from Vaisala for Very Dry Gases
- The Most Flexible Just Got More Flexible
- New Conveyor Chains for Handling of Lightweight Goods
- Intelligent Single-Piece Flow Solution by FlexLink
- Miniature Humidity Probe from Vaisala
- Use of a Modified Starch for Softgel Coating, Suitable for Food, Nutraceutical and Pharmaceutical Products
- News
- Business & Industry
- Drug Research
- Antares, Watson Pharmaceuticals launch Gelnique 3% in US
- Meridian, Teva settle epinephrine auto-injector pending patent litigation
- Affymax, Takeda launch OMONTYS injection in US
- Watson introduces generic version of Fortamet
- Elis Pharma to present erectile dysfunction drug Vitaros at Dubai event
- EyeScience develops new eye vitamin for diabetes patients
- APP Pharmaceuticals receives marketing approval for Methotrexate Injection
- Ranbaxy launches cholesterol reducing drug in Australia
- La Jolla buys GCS-100 rights from Solana
- Novartis receives Morrison & Foerster advice on Camurus deal
- Mymetics regains intra-nasal influenza vaccine from Solvay
- The Medicines Company introduces new Cleviprex formulation
- Theraclone doses first patient in Phase 1 TCN-032 drug trial
- FDA approves Amphastar Enoxaparin Sodium Injection
- Dey Pharma to provide EpiPen Auto-Injectors
- Unilife develops safety syringe to reconstitute lyophilized drugs
- Allos recruits first patient in Phase 3 PTCL drug trial
- Abbott two new strengths of CPP drug gets FDA nod
- AVI BioPharma starts patient dosing in DMG drug Phase 2 trial
- Biogen Idec, Abbott release Select Phase 2b RRMS drug trial results
- Innovacyn introduces eye, ear formulations
- Glenmark settles patent case with Daiichi, Genzyme
- RxMD signs drug development agreement with GlycoRegImmune
- Evotec, Roche collaborate to develop oncology biomarkers
- Evotec and PsychoGenics Enter into a Strategic Alliance to Provide Integrated CNS Drug Discovery Solutions
- Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Drug Delivery of BA058
- Phase 3 Data Demonstrate XGEVA(TM) (Denosumab) is First Bone Targeted Therapy to Prevent Spread of Cancer to the Bone in Men
- InhibOx and COSMIC Discoveries align to deliver full service drug discovery offering
- Lycera Announces Research Collaboration with Merck
- Shire Strengthens Specialty Pharmaceuticals Team with Senior R&D Appointments
- King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY
- King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX Tablets
- Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib
- New technique to speed up drug development
- Optimer Pharmaceuticals Completes New Drug Application for Fidaxomicin
- New data show potential for Novartis Meningitis B vaccine
- Prolia(TM) (denosumab) Receives Best New Drug Honor at Scrip Awards
- Helix BioPharma Corp. completes Definative GLP toxicology studies with L-DOS47
- B. Braun Cefepime Now Available in Duplex drug delivery system
- Newly Published Caldolor(R) Clinical Data Demonstrates 77% Reduction in Fever in Hospitalized Patients
- Scripps Research Study Challenges Conventional Theory of Modern Drug Design
- Production & Manufacturing
- Natco Pharma wins license to manufacture, sell Nexavar in India
- BioLife Solutions to build second GMP production facility
- Eurogentec drug substance manufacturing facility wins FDA nod
- Dainippon wins manufacturing approval for sleep inducing therapy in Japan
- EMA approves Genzyme Framingham manufacturing plant
- Islet Sciences chooses NeoStem unit for product manufacturing
- Bayer joins Russian firm to manufacture drugs
- AstraZeneca invests $200m to set up manufacturing facility in China
- CMC Biologics, Inspiration team up to manufacture hemophilia B drug
- Sun Pharma gets FDA acceptance for Cranbury manufacturing palnt.
- MHRA approves Ajanta Pharma Paithan manufacturing plant
- Visiongain predicts boom in pharma contract manufacturing market
- Aenova, SkyePharma in manufacturing alliance
- TPI to start test runs at JCM manufacturing plant
- Spanish regulators give manufacturing license to Midatech Biogune
- Unigene in contract manufacturing agreement with Cara
- Pharmatek adds spray drying to drug manufacturing capabilities
- APP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for Injection
- Nycomed to acquire of majority stake in Guangdong Techpool Bio-Pharma
- Merck's Investigational Medicine Boceprevir Achieved Significantly Higher SVR Rates
- Biocon and Pfizer Enter Into Global Commercialization Agreement-Deliver Essential Insulin Treatments to Diabetes Patients Worldwide
- European vaccine development moves forward
- Novartis announces agreement to develop influenza vaccines using revolutionary synthetic genomics technology
- Packaging & Labelling
- Almac Pharma Services expands packaging operations in US
- Novartis to update high blood pressure drug label
- Pfizer recalls oral contraceptives due to packaging error
- FDA approves TYSABRI label change
- Chesapeake installs new Vijuk MV-2011 folder
- Systech signs agreement with Zetes
- Chesapeake to take over Cortegra
- Healthnostics to introduce MicroFill-2160
- TGA to commence labelling, packaging regulatory review
- Marck to introduce Paracetamol IV in plastic package in India
- Merck Statement Regarding FDA Approval of Changes to Trade Packaging Design for Several Medicines from Merck
- Expansion of Packaging Technology: Bosch to take over pharmaceuticals specialists
- Althea Technologies Expands Offering To Packaging and Labeling Through A Co-Marketing Agreement With Sherpa Clinical Packaging
- Fairfield Group Launched Multi-Scan Solution for Pharmaceutical Packaging Requirements
- Romaco Group at PACK EXPO 2010 in Chicago: Ergonomic Packaging Solutions
- YORK Label and Pago Form Global Partnership-This brings two major suppliers of package decoration products
- Rexam Pharma Packaging India expands activities in India to meet the most stringent regulated requirements
- Strategy
- OncoMed Pharmaceuticals and Bayer HealthCare Expand Cancer Stem Cell Collaboration with Clinical Manufacturing Agreement
- Merck Wins First FOSAMAX] (alendronate sodium) State Court Trial
- Medicis and Anacor Enter Into Research and Development Collaboration for the Treatment of Acne
- GSK announces the sale of its entire shareholding in Quest Diagnostics
- Merck and Parexel form Strategic Allicance focused on Clinical Development
- Caraco Pharmaceutical Laboratories, Ltd. Provides Update on Remediation Activities
- EpiTherapeutics and Abbott Enter into Oncology Collaboration on Epigenetic Targets
- King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX Tablets
- Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc
- Genzyme Announces Agreement to Sell Diagnostics Business to Sekisui Chemical Co.
- Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
- Evotec AG entered License and collaboration agreement with Jingxin Pharma for EVT 201
- Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited
- GSK completes previously reported settlement with U.S. Department of Justice regarding former manufacturing plant
- Dr. Reddy’s expands portfolio in Russia & CIS through in-licensing deals.
- Helix BioPharma Files IND For Its Planned Phase II/III Efficacy Trial Of Topical Interferon Alpha-2B
- Alliance Medical Products receives commercial approval of its IMA Tube Filling Line
- Abbott to Voluntarily Withdraw Meridia® (Sibutramine) in the U.S.
- Mylan to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case
- Althea Technologies announces the Installation of a High-Speed Prefilled Syringe Line
- Clinical Trials
- Peregrine reports results from phase II front-line lung cancer trial
- Circassia reports positive results from Phase II ragweed allergy therapy study
- PhaseBio begins Phase I hypertension study with Vasomera
- TxCell reports positive immuno-monitoring results from Phase I/II Crohn's disease study
- Galena initiates Phase III PRESENT trial for NeuVax
- Genta reports Tesetaxel Phase 2b trial data
- Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
- TxCell presents final positive results of the phase I/II clinical trial with antigen-specific Treg cells in Crohn’s disease
- AstraZeneca and Forest Laboratories to initiate phase III clinical trials for ceftazidime/avibactam to treat serious Gram-negative bacterial infections
- First results from ongoing Phase III trial show malaria vaccine candidate, RTS,S* reduces the risk of malaria by half in African children aged 5 to 17 months
- Acetylon Pharma starts treating patients in Phase 1-2a multiple myeloma drug trial
- Neurocrine starts tardive dyskinesia drug Phase II trial
- Bionor Pharma to initiate HIV Vacc-4x combination trial
- Scancell updates on cancer vaccine Phase I clinical trial
- Aeras, OETC commence TB drug Phase IIb trial
- Alnylam concludes liver cancer drug Phase I trial
- Sinapis Pharma concludes Phase I stroke drug trial
- Phase 3 Study of YERVOY Metastatic Melanoma Meets Primary Endpoint of Overall Survival
- Roche announces data to show Avastin based regimen halved the risk of disease getting worse in women with recurrent ovarian cancer
- Adaptimmune announces Opening of Phase I/II Clinical Trial in Multiple Myeloma
- First ever study to apply therapeutic approach of global immune reconstitution to treatment of cancer patients
- FDA approves linagliptin tablets for the treatment of type 2 diabetes
- Gilead and MicroDose Therapeutx Announce License and Collaboration Agreement to Develop MDT-637
- Biogen Idec Receives Positive Opinion from the CHMP and Authorisation from Health Canada on AVONEX PEN
- Boehringer Ingelheim’s lead hepatitis C compound moves into phase III – the first within the BI HCV portfolio
- Addex Initiates Phase IIa Clinical Trial of Dipraglurant-IR in Parkinson’s Disease Levodopa-Induced Dyskinesia (PD-LID)
- Adocia reports positive phase I clinical results on HinsBet(R), a fast-acting human insulin
- Infinity Initiates Phase 2 Trial of IPI-926 in Patients With Chondrosarcoma
- NovaBay Pharmaceuticals Initiates Phase 2 Clinical Trial for the Treatment of Urinary Catheter
- GlaxoSmithKline and Human Genome Sciences announce publication of BLISS-52 phase lll study results
- Plexxikon Initiates Phase 1 Clinical Trial for Oral Rheumatoid Arthritis Agent PLX5622
- Sanofi-aventis Reports Top-line Results from Phase III Study with BSI-201 in Metastatic Triple-Negative Breast Cancer
- Patients enrolled in EU Phase III Clinical Development Progam to evaluate ATX-101 for Reduction of Submental Fat
- VistaGen Therapeutics Announces Successful Completion of Initial Phase 1 Safety Study of AV-101
- Gilead Terminates Phase III Clinical Trial of Ambrisentan in Patients with Idiopathic Pulmonary Fibrosis
- Genentech Phase II study shows Pertuzumab and Herceptin Plus Chemotherapy Significantly Improved the Rate of Complete Tumor
- Novartis study shows drug Afinitor plus hormonal therapy delays disease progression in advanced metastatic breast cancer patients
- Phase III study showed Rituxan/MabThera decreased the risk of needing later treatment with chemotherapy or radiotherapy by 80% by Roche
- QR Pharma receives FDA clearance to conduct clinical trials with its second novel Alzheimer compound
- Bayer and Regeneron Report Positive Top-Line Results of Two Phase 3 Studies
- Reata and Abbott Announce Positive Phase 2b Study Results for Bardoxolone Methyl
- Novartis discontinues ASA404 clinical trial program and shifts focus to other cancer compounds in early and late stage development
- Genentech announced the result of Phase II clinical trail of RG7204
- Sanofi Pasteur’s Dengue Vaccine in Final Stage of Clinical Development
- Roche reports promising Phase II results with new targeted approach in advanced melanoma
- Genzyme Announces Results of Phase 3 Trial of Clolar in Adult AML
- Boehringer Ingelheim announced approval for TWYNSTA®. TWYNSTA single pill combination that delivers powerful and consistent blood pressure reductions
- Amgen announced that results from the PRIME '203' and '181' pivotal Phase 3 trials
- Bristol-Myers Squibb announced results from a randomized, double-blind Phase 3 clinical study in adults with type 2 diabetes
- IT & Data Management
- Virginia adopts national precursor log exchange system
- Revitas Validata solution helps reduce pharma companies margin erosion
- Siemens Healthcare introduces two new cloud-based solutions
- TriCore selects 4medica iEHR for patient data integration
- Zynx supplies Prime-A-Pump tool to US medical center
- Pacific Biosciences signs deal with Cycle Computing
- Pfizer chooses iCentera Sales Enablement SaaS platform
- Acurian enters into agreement with pharma firm to handle patient data
- ETH Zurich, CloudBroker select IBM Cloud Computing
- World’s Leading Clinical Trial Investigator Portal Solution Released By InnovoCommerce LLC
- European Medicines Agency and European Network of Centres for Pharmacoepidemiology and Pharmacovigilance launch E-Register
- Desktop Medicine - New Approach To Medicine
- Smart-Pill Technology
- Novartis Pharmaceuticals AG Selects Veeva CRM for Global Deployments
- McKesson Releases New Reporting Solution for EnterpriseRx
- CRM Software Provider Partners With Eastern European Pharma Services Company
- Innovative Safety Application to Trend and Graph Laboratory Values from ICON plc
- Antares, Watson Pharmaceuticals launch Gelnique 3% in US
- Meridian, Teva settle epinephrine auto-injector pending patent litigation
- Affymax, Takeda launch OMONTYS injection in US
- Watson introduces generic version of Fortamet
- Natco Pharma wins license to manufacture, sell Nexavar in India
- Virginia adopts national precursor log exchange system
- Elis Pharma to present erectile dysfunction drug Vitaros at Dubai event
- Peregrine reports results from phase II front-line lung cancer trial
- Revitas Validata solution helps reduce pharma companies margin erosion
- Circassia reports positive results from Phase II ragweed allergy therapy study
- Almac Pharma Services expands packaging operations in US
- EyeScience develops new eye vitamin for diabetes patients
- BioLife Solutions to build second GMP production facility
- Eurogentec drug substance manufacturing facility wins FDA nod
- PhaseBio begins Phase I hypertension study with Vasomera
- Siemens Healthcare introduces two new cloud-based solutions
- Novartis to update high blood pressure drug label
- APP Pharmaceuticals receives marketing approval for Methotrexate Injection
- Ranbaxy launches cholesterol reducing drug in Australia
- TxCell reports positive immuno-monitoring results from Phase I/II Crohn's disease study
- TriCore selects 4medica iEHR for patient data integration
- Dainippon wins manufacturing approval for sleep inducing therapy in Japan
- Pfizer recalls oral contraceptives due to packaging error
- Galena initiates Phase III PRESENT trial for NeuVax
- FDA approves TYSABRI label change
- La Jolla buys GCS-100 rights from Solana
- Genta reports Tesetaxel Phase 2b trial data
- Zynx supplies Prime-A-Pump tool to US medical center
- EMA approves Genzyme Framingham manufacturing plant
- Islet Sciences chooses NeoStem unit for product manufacturing
- Chesapeake installs new Vijuk MV-2011 folder
- Novartis receives Morrison & Foerster advice on Camurus deal
- Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
- TxCell presents final positive results of the phase I/II clinical trial with antigen-specific Treg cells in Crohn’s disease
- AstraZeneca and Forest Laboratories to initiate phase III clinical trials for ceftazidime/avibactam to treat serious Gram-negative bacterial infections
- First results from ongoing Phase III trial show malaria vaccine candidate, RTS,S* reduces the risk of malaria by half in African children aged 5 to 17 months
- Bayer joins Russian firm to manufacture drugs
- AstraZeneca invests $200m to set up manufacturing facility in China
- Mymetics regains intra-nasal influenza vaccine from Solvay
- The Medicines Company introduces new Cleviprex formulation
- Acetylon Pharma starts treating patients in Phase 1-2a multiple myeloma drug trial
- CMC Biologics, Inspiration team up to manufacture hemophilia B drug
- Theraclone doses first patient in Phase 1 TCN-032 drug trial
- Neurocrine starts tardive dyskinesia drug Phase II trial
- FDA approves Amphastar Enoxaparin Sodium Injection
- Pacific Biosciences signs deal with Cycle Computing
- Sun Pharma gets FDA acceptance for Cranbury manufacturing palnt.
- Pfizer chooses iCentera Sales Enablement SaaS platform
- Systech signs agreement with Zetes
- Chesapeake to take over Cortegra
- Dey Pharma to provide EpiPen Auto-Injectors
- Bionor Pharma to initiate HIV Vacc-4x combination trial
- Unilife develops safety syringe to reconstitute lyophilized drugs
- MHRA approves Ajanta Pharma Paithan manufacturing plant
- Healthnostics to introduce MicroFill-2160
- Allos recruits first patient in Phase 3 PTCL drug trial
- Scancell updates on cancer vaccine Phase I clinical trial
- Abbott two new strengths of CPP drug gets FDA nod
- Visiongain predicts boom in pharma contract manufacturing market
- AVI BioPharma starts patient dosing in DMG drug Phase 2 trial
- Aeras, OETC commence TB drug Phase IIb trial
- Biogen Idec, Abbott release Select Phase 2b RRMS drug trial results
- TGA to commence labelling, packaging regulatory review
- Acurian enters into agreement with pharma firm to handle patient data
- Alnylam concludes liver cancer drug Phase I trial
- Aenova, SkyePharma in manufacturing alliance
- Sinapis Pharma concludes Phase I stroke drug trial
- TPI to start test runs at JCM manufacturing plant
- ETH Zurich, CloudBroker select IBM Cloud Computing
- Innovacyn introduces eye, ear formulations
- Marck to introduce Paracetamol IV in plastic package in India
- Glenmark settles patent case with Daiichi, Genzyme
- RxMD signs drug development agreement with GlycoRegImmune
- Evotec, Roche collaborate to develop oncology biomarkers
- Merck Statement Regarding FDA Approval of Changes to Trade Packaging Design for Several Medicines from Merck
- Phase 3 Study of YERVOY Metastatic Melanoma Meets Primary Endpoint of Overall Survival
- Roche announces data to show Avastin based regimen halved the risk of disease getting worse in women with recurrent ovarian cancer
- Spanish regulators give manufacturing license to Midatech Biogune
- Adaptimmune announces Opening of Phase I/II Clinical Trial in Multiple Myeloma
- Evotec and PsychoGenics Enter into a Strategic Alliance to Provide Integrated CNS Drug Discovery Solutions
- Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Drug Delivery of BA058
- Unigene in contract manufacturing agreement with Cara
- Phase 3 Data Demonstrate XGEVA(TM) (Denosumab) is First Bone Targeted Therapy to Prevent Spread of Cancer to the Bone in Men
- First ever study to apply therapeutic approach of global immune reconstitution to treatment of cancer patients
- FDA approves linagliptin tablets for the treatment of type 2 diabetes
- Expansion of Packaging Technology: Bosch to take over pharmaceuticals specialists
- Pharmatek adds spray drying to drug manufacturing capabilities
- Althea Technologies Expands Offering To Packaging and Labeling Through A Co-Marketing Agreement With Sherpa Clinical Packaging
- OncoMed Pharmaceuticals and Bayer HealthCare Expand Cancer Stem Cell Collaboration with Clinical Manufacturing Agreement
- Gilead and MicroDose Therapeutx Announce License and Collaboration Agreement to Develop MDT-637
- Biogen Idec Receives Positive Opinion from the CHMP and Authorisation from Health Canada on AVONEX PEN
- Boehringer Ingelheim’s lead hepatitis C compound moves into phase III – the first within the BI HCV portfolio
- Addex Initiates Phase IIa Clinical Trial of Dipraglurant-IR in Parkinson’s Disease Levodopa-Induced Dyskinesia (PD-LID)
- Adocia reports positive phase I clinical results on HinsBet(R), a fast-acting human insulin
- InhibOx and COSMIC Discoveries align to deliver full service drug discovery offering
- Infinity Initiates Phase 2 Trial of IPI-926 in Patients With Chondrosarcoma
- Lycera Announces Research Collaboration with Merck
- NovaBay Pharmaceuticals Initiates Phase 2 Clinical Trial for the Treatment of Urinary Catheter
- Merck Wins First FOSAMAX] (alendronate sodium) State Court Trial
- Medicis and Anacor Enter Into Research and Development Collaboration for the Treatment of Acne
- Shire Strengthens Specialty Pharmaceuticals Team with Senior R&D Appointments
- GlaxoSmithKline and Human Genome Sciences announce publication of BLISS-52 phase lll study results
- GSK announces the sale of its entire shareholding in Quest Diagnostics
- Plexxikon Initiates Phase 1 Clinical Trial for Oral Rheumatoid Arthritis Agent PLX5622
- Sanofi-aventis Reports Top-line Results from Phase III Study with BSI-201 in Metastatic Triple-Negative Breast Cancer
- APP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for Injection
- Fairfield Group Launched Multi-Scan Solution for Pharmaceutical Packaging Requirements
- Merck and Parexel form Strategic Allicance focused on Clinical Development
- Patients enrolled in EU Phase III Clinical Development Progam to evaluate ATX-101 for Reduction of Submental Fat
- Caraco Pharmaceutical Laboratories, Ltd. Provides Update on Remediation Activities
- King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY
- VistaGen Therapeutics Announces Successful Completion of Initial Phase 1 Safety Study of AV-101
- Gilead Terminates Phase III Clinical Trial of Ambrisentan in Patients with Idiopathic Pulmonary Fibrosis
- EpiTherapeutics and Abbott Enter into Oncology Collaboration on Epigenetic Targets
- King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX Tablets
- King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX Tablets
- Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc
- Genentech Phase II study shows Pertuzumab and Herceptin Plus Chemotherapy Significantly Improved the Rate of Complete Tumor
- Novartis study shows drug Afinitor plus hormonal therapy delays disease progression in advanced metastatic breast cancer patients
- Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib
- Phase III study showed Rituxan/MabThera decreased the risk of needing later treatment with chemotherapy or radiotherapy by 80% by Roche
- QR Pharma receives FDA clearance to conduct clinical trials with its second novel Alzheimer compound
- New technique to speed up drug development
- Optimer Pharmaceuticals Completes New Drug Application for Fidaxomicin
- World’s Leading Clinical Trial Investigator Portal Solution Released By InnovoCommerce LLC
- European Medicines Agency and European Network of Centres for Pharmacoepidemiology and Pharmacovigilance launch E-Register
- Bayer and Regeneron Report Positive Top-Line Results of Two Phase 3 Studies
- Reata and Abbott Announce Positive Phase 2b Study Results for Bardoxolone Methyl
- Genzyme Announces Agreement to Sell Diagnostics Business to Sekisui Chemical Co.
- Novartis discontinues ASA404 clinical trial program and shifts focus to other cancer compounds in early and late stage development
- Desktop Medicine - New Approach To Medicine
- Smart-Pill Technology
- New data show potential for Novartis Meningitis B vaccine
- Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
- Genentech announced the result of Phase II clinical trail of RG7204
- Prolia(TM) (denosumab) Receives Best New Drug Honor at Scrip Awards
- Sanofi Pasteur’s Dengue Vaccine in Final Stage of Clinical Development
- Evotec AG entered License and collaboration agreement with Jingxin Pharma for EVT 201
- Roche reports promising Phase II results with new targeted approach in advanced melanoma
- Nycomed to acquire of majority stake in Guangdong Techpool Bio-Pharma
- Merck's Investigational Medicine Boceprevir Achieved Significantly Higher SVR Rates
- Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited
- GSK completes previously reported settlement with U.S. Department of Justice regarding former manufacturing plant
- Dr. Reddy’s expands portfolio in Russia & CIS through in-licensing deals.
- Genzyme Announces Results of Phase 3 Trial of Clolar in Adult AML
- Romaco Group at PACK EXPO 2010 in Chicago: Ergonomic Packaging Solutions
- Helix BioPharma Files IND For Its Planned Phase II/III Efficacy Trial Of Topical Interferon Alpha-2B
- Alliance Medical Products receives commercial approval of its IMA Tube Filling Line
- Abbott to Voluntarily Withdraw Meridia® (Sibutramine) in the U.S.
- Mylan to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case
- Novartis Pharmaceuticals AG Selects Veeva CRM for Global Deployments
- Biocon and Pfizer Enter Into Global Commercialization Agreement-Deliver Essential Insulin Treatments to Diabetes Patients Worldwide
- Helix BioPharma Corp. completes Definative GLP toxicology studies with L-DOS47
- YORK Label and Pago Form Global Partnership-This brings two major suppliers of package decoration products
- B. Braun Cefepime Now Available in Duplex drug delivery system
- European vaccine development moves forward
- Boehringer Ingelheim announced approval for TWYNSTA®. TWYNSTA single pill combination that delivers powerful and consistent blood pressure reductions
- McKesson Releases New Reporting Solution for EnterpriseRx
- CRM Software Provider Partners With Eastern European Pharma Services Company
- Newly Published Caldolor(R) Clinical Data Demonstrates 77% Reduction in Fever in Hospitalized Patients
- Scripps Research Study Challenges Conventional Theory of Modern Drug Design
- Novartis announces agreement to develop influenza vaccines using revolutionary synthetic genomics technology
- Amgen announced that results from the PRIME '203' and '181' pivotal Phase 3 trials
- Bristol-Myers Squibb announced results from a randomized, double-blind Phase 3 clinical study in adults with type 2 diabetes
- Althea Technologies announces the Installation of a High-Speed Prefilled Syringe Line
- Innovative Safety Application to Trend and Graph Laboratory Values from ICON plc
- Rexam Pharma Packaging India expands activities in India to meet the most stringent regulated requirements
- Drug Research
- Suppliers
- Product Showcase
- Prefilled Injection Systems
- ADME -Tox Studies Benefit from Advances in Evaporative Sample Preparation
- Bürkert presents new transmitters for different sensor types
- Epichem for API Degradants and Impurities for QA/QC and Product Development
- INTEGRA VIAFLO - GripTips™ are a next generation range of pipette tips that ensure the perfect connection between pipette and tip.
- Reduce process costs with the NEW Unistat 905w from Huber
- Pfeiffer Vacuum is one of the world’s leading manufacturers of components and systems for vacuum generation, measurement and analysis.
- Award-Winning Pfeiffer Vacuum Catalog
- NEW Agilent 4100 MP-AES
- Starna extends range of CRMs to cover Far UV to NIR spectral region
- Solvias offers increased capacity and profound know-how for analytical and chemical development
- Avantis New Synthetic Vaccine Adjuvant
- INTEGRA VIAFLO - GripTips™ are a next generation range of pipette tips that ensure the perfect connection between pipette and tip.
- Key Account Management 2010
- Definitive Publishing for International Pharma Professionals
- BioCisions CoolCell – highly reproducible, superior cell freezing
- Profiles
- Search
- Product Showcase
- Conferences & Events
- Contact Us
